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ABSTRACT 
Tilapias show a variety of physiological adaptations that allow them to live in different 
environmental conditions, disturbing local ecosystems where they are introduced by human 
hand, where they reproduce at faster rates as their cycles are short and constant. They have 
complex behaviours, with species in the Oreochromis and Sarotherodon genus exhibiting 
parental care. Thus, they have become a preferred research species. Knowledge on their 
physiology might benefit the medical sciences, the fisheries industry, environmentsl sciences 
and aquaculture, which is still the major player in sex genes research, as tilapias fish are the 
second most cultured species worldwide and there are problems with their high spawning rates 
as these originate high density stocks in tanks. There is considerable information concerning 
the hypothalamus-pituitary-gonadal axis in vertebrates, with gonadotrophins (FSH and LH) 
playing stimulating roles in development of the ovary and maturation of oocytes. Other 
hormones and factors are involved, mediating the actions of these or as products of their 
induction. The early stages of development of the ovarian follicle and the enveloped oocytes 
are still poorly described, with FSH being considered the first inducer for decades. This implies 
a role for local factors that are regulating the early stages of growth. Recently, TGF-β family 
member activin has been shown to induce FSH incorporation by the follicles and other 
members of this family also seem to have an important role in the ovary, such as BMPs and 
GDFs. Some other factors were studied in this thesis for expression patterns throughout oocyte 
development. With this objective, ovaries from 8 females were extracted and dissected under a 
binocular amplifier with groups of oocytes in 4 different stages being collected for each. RNA 
was extracted and purified and turned into cDNA by reverse transcription. Genes with 
preferential expression in ovary (determined by subtractive hybridization and then with semi-
quantitative RT-PCR) were tested by RT-PCR in oocytes and band intensity was quantified 
using Quantity One from Biorad, using as reference 18S rRNA. These genes include FoxL2, 
CYP19a, Vasa, RBMX, BMP-R IB, CPI-17, Aly and other unidentified fragments: SART, 
PPMP (homolog sequences but not confirmed) and XP2 (putative new protein) and clone 26 
(no homolog sequence known). Results show significant differences among the 4 oocyte stages 
for practically every gene tested, except for Aly and SART. Correlations among some of the 
genes also show they might have related functions in the process.  
 
KEY-WORDS: Molecular endocrinology, oocyte, oogenesis, semi-quantitative RT-PCR, tilapia. 
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RESUMO 
As tilápias possuem uma grande variedade de adaptações fisiológicas que lhes permitem resistir a 
diferentes condições ambientais, tendo-se tornado invasoras por introdução pelo Homem, como 
consequência dos seus ciclos reprodutivos mais rápidos e constantes, que perturbam os ecossistemas 
locais. Estes factores e os seus hábitos comportamentais como o cuidar dos ovos e juvenis até estes 
estarem mais aptos à sobrevivência tornam-nas alvos de estudo intensivo. Este tipo de pesquisa pode 
beneficiar a medicina, as ciências ambientais, a indústria pesqueira e a aquacultura, sendo esta última a 
área que actualmente mais se dedica à investigação de genes envolvidos em processos fisiológicos 
reprodutivos em teleósteos. Dos problemas que se encontram na cultura de tilápias salientam-se as 
elevadas taxas de reprodução que criam stocks demasiado densos nos tanques, e os maiores problemas 
surgem com as fêmeas, pois para além de crescerem menos, a fisiologia e regulação do ovário ainda tem 
muito por descobrir. Sabe-se que a nível endócrino o eixo hipotálamo-pituitária-gónada regula o 
desenvolvimento através de gonadotropinas (FSH e LH), que têm papéis chave na formação do folículo 
que envolve os óocitos e na maturação destes. Outras hormonas têm já efeitos conhecidos, mas 
examinando o início do processo percebe-se que tem de haver factores locais a controlar o 
desenvolvimento. A activina, um membro da família TGF-β mostrou ser responsável pela indução da 
incorporação de FSH no folículo, e outros membros desta família parecem desempenhar um papel de 
relevo na regulação do ovário, como BMPs e GDFs. Nesta tese pretendeu-se identificar a actividade 
destes factores putativos ao longo da oogénese. Para isso foram extraídos ovários a 8 fêmeas, sendo estes 
dissecados de modo a separar 4 estádios de desenvolvimento dos oócitos. O RNA foi extraído, purificado 
e construiu-se o cDNA para cada 4 dos tecidos de cada fêmea. Por hibridização subtractiva e 
posteriormente por RT-PCR semi-quantitativo determinaram-se que genes testar, escolhendo-se os que 
tinham expressão preferencial no ovário. Esses genes foram então testados por sua vez com RT-PCR aos 
oócitos das várias fêmeas, e a sua expressão quantificada com o software Quantity One da Biorad, usando 
o RNA ribossomal 18S como referência. Genes testados incluem: FoxL2, CYP19a, Vasa, RBMX, BMP-R 
IB, CPI-17, Aly e outros fragmentos não identificados: SART, PPMP (sequência homóloga mas não 
comprovada), XP2 (uma possível nova proteína) e o clone 26, este último sem homologia com nenhuma 
outra sequência conhecida. Os resultados obtidos sugerem uma expressão distinta ao longo dos diferentes 
estados de crescimento dos oócitos para praticamente todos os genes, excepto o Aly e o SART. 
Correlações entre genes mostram que alguns deles podem ter funções relacionadas.    
 
PALAVRAS-CHAVE: Endocrinologia molecular, oócitos, oogénese, RT-PCR semi-quantitativo, tilápia. 
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1. INTRODUCTION  
The processes regulating ovarian development are still largely unknown, particularly for 
teleosts. The majority of the data concerns mammals, with emphasis on the human ovary. During 
the last decade however, teleosts fish, which represent 95% of all vertebrate species (Redding and 
Patiño 2000a), have become important research subjects in the field of endocrinology 
(particularly salmonids), as they have a diversity of physiological adaptations to various habitats, 
offering virtually every conceivable type of ovarian physiology and providing exploitable 
material for the understanding of mechanisms regulating ovarian recrudescence (Wallace and 
Selman 1981). Reproduction strategies include oviparity, ovoviviparity and viparity, with some 
of the species exhibiting parental care, as is the case of tilapias. Studies tend to focus on species 
of economic value, as is the case of some species of tilapia. Tilapiine fish have become the 
second most cultivated species worldwide, as a result of their ease of culture, tolerance to poor 
water quality and extreme conditions. Females receive extra attention from researchers because it 
is harder to maintain captive females. The problems involving the culture of tilapias consist in 
some intolerance to some physical properties of water and reproduction difficulties of females, 
with ovarian cycles restarting immediately after the last ovulation and lasting for different periods 
of time. To overcome these problems of female reproduction cycles it is necessary a deeper 
understanding of the functioning of the ovary and how its developmental processes are being 
regulated. On a general basis this type of research is contributing for the increased knowledge of 
the vertebrate ovary and that of teleosts. With molecular and cellular biology it is now possible to 
study physiology at the transcription level, a fact that led to an explosive growth in the discipline 
of endocrinology, with several more messenger molecules being identified through mRNA 
analysis of transcribed genes in the various tissues. The present thesis is aimed at identifying the 
factors that may be involved in regulatory processes during ovarian recrudescence of a tilapiine 
fish, the Mozambique tilapia (Oreochromis mossambicus, fig. 1).   
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1.1. TILAPIA BIOLOGY AND VALUE 
         Cichlid fishes have received wide 
attention from evolutionary biologists for 
more than 100 years because of their 
extremely diverse morphology, behaviour, 
and ecology (Klett and Meyer 2002). This 
perciform fish family is one of the most 
species-rich families of vertebrates with at 
least 1,300 and perhaps as many as 1,870 
species (Katagiri, et al. 2005; Klett and 
Meyer 2002).  Of  these,   more  than  70  are 
 
 
Fig.1 – A female Mozambique tilapia (Oreochromis 
mossambicus) was the species used for this study. 
Illustration by Gunther Schmida in Mackenzie, et al. 
2001.   
referred to as tilapia, a   generic    term   used    to   designate   a   group   of  commercially 
important   food  fish  that  exhibit  a  wide  spectrum  of ecological adaptations and tolerances 
(pH, temperature, salinity, oxygen tension, overcrowding) (De Silva, et al. 2004). They are multi-
spawning fish, with reproductive cycles in average 15-20 days (Coward and Bromage 2000). 
Their enormous adaptability to the most diverse environments reveals their potential as a cultured 
species, as well as explaining why they have become invaders of so many other habitats where 
they didn’t belong, by human introduction (Bwanika, et al. 2004). The Mozambique tilapia 
(Oreochromis mossambicus) was the first to be dispersed, but its precocious maturity and 
tendency to overpopulate make them not as suitable for culture as other tilapia species (Lim and 
Webster 2006). O. mossambicus breeds throughout the year in equatorial waters, with peaks 
usually in the rain season. They are maternal mouthbrooders, like all fishes in the Oreochromis 
genus. The males construct nests in firm sand, where the females leave their gametes to be 
fertilized by male sperm, and after females collect the eggs into their mouth where they will 
remain even after hatching, until the fry don’t need their care. Females have asynchronous 
ovaries, being multiple spawners with variable interspawning intervals (Coward and Bromage 
2000), the ovary regenerates quickly but not at constant rates and egg size may vary between 
populations of the same species (Tyler and Sumpter 2004). Their fecundities vary with size and 
they grow 20 to 60% less than males. Tilapias are therefore fascinating creatures to study 
physiological adaptations. 
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1.1.1. IMPORTANCE 
Knowledge of ovarian follicle growth in teleosts may provide information not only for 
basic research, but also in biomedical sciences, fisheries management, environmental science and 
aquaculture.  In the environmental sciences knowledge on the effects of endocrine disruptors on 
ovary function may provide a way to detect pollutants in waters. Endocrine disruptors disturb 
hormone actions, having effects on a variety of organisms sensitive to the disruptor. For 
medicine, discovery of new functions of genes like FoxL2, a gene from the forkhead family of 
transcription factors, may provide insights into diseases like premature ovarian failure (POF) 
(Pisarska, et al. 2004; Wang, et al. 2004), blepharophimosis/ptosis/epicanthus inversus syndrome 
or BPES (Baron, et al. 2004; Ottolenghi, et al. 2005; Pannetier, et al. 2006; Uhlenhaut and Treier 
2006) and pooled intersex syndrome in goat (PIS) (Ottolenghi et al. 2005; Uhlenhaut and Treier 
2006; Wang, et al. 2007), which are caused by mutations in this gene. It may also help on the 
fertility control area (Lerch, et al. 2007). In fisheries, information on ovary and reproduction may 
one day provide solutions for reproduction alternatives for increasing the declining fish stocks 
around the world. But the main area of interest in sex related genes comes from aquaculture. 
Manipulation of sexual phenotypes and selection of desired sex-linked traits like size, growth rate 
or egg production, are already well underway (Bwanika et al. 2004; Charo-Karisa, et al. 2006; 
Hassanien and Gilbey 2005; Hulata 2001; Katagiri et al. 2005; Pechsiri and Yakupitiyage 2005; 
Shirak, et al. 2006), but solutions to the problems involving sexual cycles of tilapias are still 
lacking. This is a species whose culture will continue to grow, and they are already among the 
most cultivated fish worldwide. They are second only to Carp which account for 75% of total 
global aquaculture (De Silva et al. 2004; Lim and Webster 2006; Muir and Young 1998), 
particularly the genus Oreochromis spp.. Native to African rivers, several species have been 
introduced to tropical areas of Asia and the Americas to increase supplies of animal protein (Lee, 
et al. 2005). World aquaculture production of tilapia now exceeds 1.5 million tons per year as 
shown in figure 2 (De Silva et al. 2004; Katagiri et al. 2005; Lee et al. 2005) (Fig. 2). 
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Fig. 2 – Aquaculture production of tilapias worldwide. The majority of aquaculture production comes from Asia and 
the major importer the USA; Europe is not a strong competitor with main importers being the United Kingdom, 
France, Belgium, Germany and the Netherlands, around big cities with large African and Asian communities (De 
Silva et al. 2004). 
 
Tilapias have been successful as a cultured species group in the tropical countries due to: 
ease of culture (and thus relatively less limited by the economic status of the farmer), relevant 
species exhibiting many of the desirable traits expected of a species suitable for culture, like high 
growth rate, wide range of tolerance to physical-chemical characteristics (Hulata 2001; Pechsiri 
and Yakupitiyage 2005), exhibiting ecological adaptations and high tolerances (Hassanien and 
Gilbey 2005; Klett and Meyer 2002). They are also disease resistant, of easy propagation, having 
long shelf-life and lending themselves to industrial preparations better than most other white fish 
(De Silva et al. 2004; Pechsiri and Yakupitiyage 2005). In addition, most of the commonly 
cultured tilapias are easily weaned on to artificial feeds. Of them the most important cultured fish 
species is Oreochromis niloticus, known as the Nile tilapia, its hybrids (Charo-Karisa et al. 
2006), the Mozambique tilapia and the blue tilapia (O. aureus) (Coward and Bromage 2000; De 
Silva et al. 2004). The ability to easily adapt to a variety of different environments makes tilapia a 
good model to study physiological adaptations (Lee et al. 2005), besides the prominent role in 
aquaculture. All said, research on physiology of tilapia is focused on defining the developmental 
organization and mechanisms of the female gonad (Redding and Patiño 2000a). Although the 
majority of these studies focus on the Nile tilapia, the Mozambique tilapia is quite similar in most 
aspects and is also a good model.  
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1.2. OVARIAN RECRUDESCENCE IN TELEOSTS 
Ovarian recrudescence can be described as a gathering of all the following processes, and 
although they normally occur somewhat in this order, it is not a rule: oogonial proliferation, 
oogenesis, folliculogenesis (formation of the ovarian follicle), cortical alveolar formation, 
vitellogenesis, final maturation of oocytes and ovulation (Coward and Bromage 2000; Patiño and 
Sullivan 2002; Tyler and Sumpter 2004; Wallace and Selman 1990). These processes will likely 
not happen in this specific order, particularly in fish like tilapia. Instead, some of these phases 
will overlap at the ovary but also oocyte level (Coward and Bromage 2000). In tilapia, the ovaries 
contain always every stage of oocyte growth, and as soon as they ovulate, there will be oogonia 
ready to start meiosis, as well as other stages of oocytes that will be included in the ovarian cycle 
at a later time. Oogenesis is complemented with folliculogenesis, as the basic structure of the 
ovarian follicle is established when granulosa cells and the membrane adjacent to them (theca) 
envelop oocytes at its late pachytene or early diplotene stages during their first meiotic step. So 
the two processes should actually be seen as one, as there will be exchanges between the follicle 
and oocytes that will be regulating the growth of the latter (Ravaglia and Maggese 2003). 
However, this study was done at the oocyte level, so we will focus on oogenesis, but not 
discarding the important role of the follicle. 
 
1.2.1. OOGENESIS 
Oogenesis (fig. 3) is the process by which primordial germ cells (PGC) develop into ready 
to be fertilized oocytes during two meiotic divisions with meiotic arrests in between (Patiño and 
Sullivan 2002). Others tend to designate oogenesis only as the early development of primary 
oocytes (Wallace and Selman 1990), after which the follicle envelopes the oocytes. This shows 
the tremendous ambiguity in the designation of the several stages of this process and of the whole 
process of recrudescence of the ovary in teleosts. This division is sometimes based on 
developmental stages, but in others is more complex, when used to study physiological and 
cellular processes, and to show the inconsistency of such classifications, these can be even taxon-
specific. So, depending on the area the researcher is working, there will be differently limited 
steps describing the whole ovarian development and the majority of literature these days takes 
into account the ovarian development from a follicle point of view, as the oocyte starts to grow 
significantly with the onset of folliculogenesis. Crudely, we can identify a pre-vitellogenic stage 
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that precedes a vitellogenic phase when vitellogenins (VTGs) start to be incorporated by the 
oocytes, and a final oocyte maturation stage in a post-vitellogenic phase, after which the mature 
oocytes are ready to be released and fertilized.  
 
Fig. 3 – Oogenesis and follicle envelopment of oocytes. Primordial germ cells (PGC) migrate to germinal ridge and 
go through mitotic divisions differentiating into oogonia. Oogonia stay in interphase until beginning of meiosis 
(primary oocytes). The oocytes start to be enveloped by follicular cells until the latter is completely differentiated 
and at the end of pachytene phase, early diplotene, meiosis is arrested. During this arrest VTGs are incorporated by 
the oocytes which grow considerably. At this time there is also much mRNA being produced and proteins being 
formed. Finally meiosis is resumed when the nucleus matures and finally the cytoplasm matures with yolk globules 
fusing and germinal vesicle breakdown (GVBD) (Adapted from Abascal and Medina 2005; Coward and Bromage 
2000; Goetz and Garczynski 1997; Patiño and Sullivan 2002; Wallace and Selman 1981 and Wallace and Selman 
1990). 
 
 
1.2.1.1. PRE-VITELLOGENIC GROWTH AND ONSET OF FOLLICULOGENESIS 
Little is known about the mechanisms that control pre-vitellogenic stages of oocyte 
growth, not only in teleosts but in vertebrates in general. This phase is characterized by the 
formation of PGC (primordial germ cells) and after occurs the sex differentiation and they 
become oogonia instead of spermatozoids, determined by the maternal genome (Patiño and 
Sullivan 2002). There are some putative genes responsible for this differentiation, but a sex 
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determining gene is not yet known, the process being probably a product of the action of various 
genes. The next step is the transformation of oogonia into oocytes and the meiotic division starts 
(Patiño and Sullivan 2002). Primary oocyte growth features intense transcriptional activity and 
the formation of yolk vesicles (Abascal and Medina 2005; Wallace and Selman 1981), being this 
the first gonadotropin-dependent stage. These vesicles are precursors to the cortical alveoli and 
will be filled only in the vitellogenic phase with VTGs. Cortical alveoli will be filled with 
glycoproteins in mid to late vitellogenic growth (Patiño and Sullivan 2002). It’s also at this point, 
at its late pachytene, early diplotene (Prophase I) that the ovarian follicle restarts to develop 
(Abascal and Medina 2005). At the end of diplotene phase meiosis is arrested until final 
maturation of the oocyte (Hammes 2004; Huertas 2006).  
 
Folliculogenesis is considered to be a continuous process (Findlay, et al. 2002), starting 
when granulosa cells envelope the oocytes, which in turn are enveloped by theca cells. These 
suffer a number of modifications along the process, as they first become cuboidal then cylindrical 
(Francolini, et al. 2003) and oocyte cytoplasm organelles and volume increase (Patiño and 
Sullivan 2002) by around one order of magnitude. Following oocyte envelopment, the cortical 
alveoli appear, with the Golgi apparatus of oocytes having an important role during their 
formation (Abascal and Medina 2005). Microvilli start to form in the middle of this phase at the 
oocyte surface directed to the granulosa cells, and a vitelline envelope is formed from the oocyte 
end of the microvillar structures, and as the follicle grows, oocytes and follicle become 
connected, allowing communication between them. Granulosa cells are responsible for 
mechanical support of the oocyte, besides mediating signals between the oocyte and the outer 
theca cells. The follicle will be working together with the oocytes until release of the mature 
oocytes (Lerch et al. 2007).  
 
During previtellogenic growth large quantities of ribosomal and heterogeneous RNA are 
produced by nucleoli located at the periphery of the nucleus, being much of the mRNA produced 
done so during this stage (like VTG receptor and VTG processing enzyme), declining during 
vitellogenesis as they are translated into proteins that will incorporate VTG from the blood 
stream (Wallace and Selman 1981), passing to another phase of the development.  
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1.2.1.2. VITELLOGENIC GROWTH 
Vitellogenic growth happens when VTGs (yolk proteins) start to be incorporated by the 
oocytes, being this the phase when the significant growth of the oocyte occurs. These VTGs are 
synthesized in the liver, being stimulated by hormones like 17-β estradiol and others (endocrines 
described in next section), by receptor mediated endocytosis (Coward and Bromage 2000). Their 
hepatic production starts with signalling from the hypothalamus-pituitary-gonad neuroendocrine 
axis stimulated by both endogenous and exogenous cues. When VTGs reach the ovary they enter 
the follicle through the capillaries located in the thecal cells membrane, then through the 
membrane separating theca and granulosa cells and finally through pore canals of the vitelline 
envelope that surround the microvillar structures until it reaches the oocytes and binds to VTG 
receptors (VTG-R), being finally incorporated by the oocytes. Inside they are still cleaved into 
yolk proteins in the vesicles formed during the previtellogenic stage, in the periphery of the inner 
oocyte membrane, where they will remain stored for feeding the embryo once the oocyte is 
fertilized. VTG-R mRNA hits a peak at the end of the previtellogenic stage and declines during 
vitellogenesis, suggesting the receptors are taken back to the surface for incorporation of more 
VTGs. 
 
1.2.1.3. POST-VITELLOGENIC GROWTH (FINAL OOCYTE MATURATION, 
FOLLICLE RUPTURE AND OVULATION) 
The process of ovulation is described as the release of a mature oocyte from the follicle 
and maturation represents the final stage in the oocyte development (Wallace and Selman 1981). 
However, several preparatory steps take place before the oocyte release (Goetz and Garczynski 
1997), including the resumption of the first meiotic step (Cardinali, et al. 2004), fusing of yolk 
globules, disruption of the microvillar structures that connect the oocyte to the follicle (rupture of 
the follicle by proteases). At this time the nucleus is mature (as meiosis first step is resumed) and 
finally the cytoplasm, occurring water uptake in many teleosts (Huertas 2006; Nagahama, et al. 
1993) for oocyte hydration and the volume of the oocyte grows even more. Before ovulation 
there is a new meiotic arrest in metaphase II (Hammes 2004). In tilapia, when the oocyte is 
finally released is covered by a thin acellular envelope that is formed during the follicle 
development (Francolini et al. 2003), the vitelline envelope (VE), constituted by a thin outer layer 
and a thick inner layer. The inner layer is fibrous, striated and primarily composed of 3-4 
subunits derived from VE precursor proteins, the ‘choriogenins’. The outer layer is rich in 
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polysaccharides (Patiño and Sullivan 2002). The VE acts as a mediator between the embryo and 
the environment and may have a role in fertilization (Ravaglia and Maggese 2003). When the egg 
is fertilized, it induces completion of the second meiotic division and expulsion of the second 
polar body (Patiño and Sullivan 2002). The endocrine regulation of this and the previous stages 
will be described in the following section.  
 
 
1.3. ENDOCRINE MECHANISMS OF REGULATION  
The endocrine system is mainly responsible for chemical communication between cells via 
a chemical messenger (Janz 2000), coordinating several physiological processes such as 
development, growth, homeostasis, energy availability, behaviour and reproduction. It works side 
by side with the nervous system, even sharing intracellular signalling pathways, the involvement 
of the immune system and neuroendocrine mechanisms. These systems are responsible for the 
regulation of all physiological phenomena, and knowledge on it may provide solutions for 
problems in the most diverse areas. There are four major categories of messenger molecules: 
amines, steroids, lipids and peptides. Here we will focus on peptide hormones. Exploring the 
tissues where hormones are expressed or released and their function reveals where and why these 
mechanisms are taking place. Hormones work by connecting to receptors in the target tissues, 
existing four mechanisms by which hormones signal the consequent molecules of a pathway. In 
one of these the receptor is inserted in the plasma membrane and requires coupling to enzymes 
via the G proteins (guanine nucleotide binding proteins) and a second messenger is catalyzed, 
like with TGF-β members. Another type sees the receptor itself possessing enzymatic activity, 
from the moment of hormone binding. Others form ion channels that open or close upon binding 
of hormone and a final type of receptor binds directly to the DNA, working as a transcription 
factor once the hormone binds (nuclear receptors), used by most steroid hormones.  
  
1.3.1. THE HYPOTHALAMUS-PITUITARY-GONADAL AXIS 
There is more than one type of GnRH (gonadotopin-releasing hormone) among fish, with 
these exhibiting several patterns of distribution. However, it is generally accepted that the 
neurosecretory nuclei of the hypothalamus segregates GnRH at the preoptic and anterior part of 
the brain, having an important role in reproduction (Bentley 1998; Redding and Patiño 2000b), as 
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these will stimulate the release of gonadotropins by the pituitary. The latter is composed of two 
parts, the adenohypophysis and the neurohypophysis. Unlike the majority of vertebrates vascular 
communication among these two is practically non-existent (Redding and Patiño 2000b). In the 
adenohypophysis specialized cells (gonadotrops) produce the two gonadotropins, but a single 
GTH may occur in some species. These cells’ activity is regulated by stimulating and inhibiting 
factors, being the major stimulus by the hypothalamus synthesized GnRH. FHS and LH will be 
transported in the blood stream until it reaches the gonad, at different periods of its development. 
FSH seems to be mainly responsible for early gonadal development and vitellogenesis in females. 
LH levels are low until the period of final oocyte maturation (Feist and Schreck 1996). The 
adenohypophysis also produces thyroid-stimulating hormones, prolactin family (includes 
prolactin, growth hormone and somatolactin), adrenocorticotropin and melanotropin. Prolactins 
have been shown to have effects in reproduction in some species, and thyroid hormones (T3 and 
T4 segregated from thyroid by thyroid-stimulating hormone) have been shown to be incorporated 
by tilapia oocytes (Tagawa and Brown 2001; Tagawa, et al. 2000). 
 
 
Fig. 4 - Schematics of pathways of the hypothalamus-pituitary-gonadal axis in teleosts described through section 
1.3.2.. 
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1.3.1.1. HYPOTHALAMUS AND PITUITARY HORMONES 
At the hypothalamus level, 3 types of hormones are probably involved in reproduction 
control: the already mentioned GnRH, GHRH (growth hormone-releasing hormone or 
somatocrinin) and PACAP (pituitary adenylate cyclase activating polypeptide). The first has as 
target the pituitary and the latter two have been shown to be expressed in several tissues like 
brain, stomach, heart, testes and ovary, but are differently expressed along tissues of different 
species. PACAP has been found also at the pituitary and heart of gold fish (Carassius auratus). 
GHRH acts at the anterior pituitary cells to release GH. GnRH can be found usually in two or 
more forms in each species. Its gene codes also for an associated peptide (GAP) and a signal for 
processing the preprohormone peptide. GAP function remains unknown.   
In the pituitary, the GH can be stimulated or inhibited. Stimulus is caused by GHRH, 
GnRH, dopamine, thyrotropin-releasin hormone, neuropeptide Y (NPY) and cholecystokinin. 
Inhibition happens with somatostatin (somatotropin-release inhibiting factor or SRIF), IGFs 
(insulin-like growth factors), GH, glutamate, norepinephrine and serotonin. GH promotes somatic 
growth in fish. When GH is released it promotes transcription and release of insulin-like growth 
factors (IGF I and IGF II) in several tissues (Kajimura 2004). FSH and LH are released from the 
pituitary when GnRH binds to the respective receptors on the gonadotrops outer membrane and 
they will act mainly at the gonads level. In females GTHs target is the follicle, acting on the 
granulosa and the thecal cells that surround the oocyte, but not the oocyte itself. FSH-R binds 
both GTHs (but mainly FSH) and LH-R binds specifically LH. The first is found in both types of 
follicle cells but the second only in granulosa cells. These receptors are G-protein-coupled, 
stimulating adenylyl cyclase and cAMP in both gonads (Gill and Hammes 2007). But other 
signalling mechanisms are necessary in this signalling process, including IP3 production, 
increases in intracellular calcium, protein kinase C activity and arachidonic acid metabolites (Pati 
and Habibi 2002).  
 
 
1.3.1.2. OVARY HORMONES 
Action of GTHs is not straightforward, being mediated by steroids (Nagahama et al. 
1993) produced at the follicle cells (Redding and Patiño 2000a; Rocha and Reis-Henriques 1998). 
In response to FSH that enters these cells mediated by receptors, follicle thecal cells produce and 
release testosterone (T), one of the main sex steroids working in fish reproduction cycles. T 
 
12
diffuses to the granulosa cells and is converted into 17β-estradiol (E2) by aromatase from the 
cytochrome P450 family of enzymes. This family is the main responsible for the biosynthetic 
pathways in fish, regulating production of sex steroids. These latter are fused ring structures 
derived from cholesterol by the ‘side chain cleavage’ of cholesterol by enzyme P450scc. 
Progesterones also have an important role, with 17α,20β-DP being the most well known oocyte 
maturation inducer, responsible for further follicle rupture with ready to be fertilized oocytes’ 
release. IGF-I expression has been found in ovaries among other tissues, and IGF-II is expressed 
during vitellogenesis. Its main role is to mediate GH effects, but gonadal IGFs found in granulosa 
and thecal cells (Kajimura, et al. 2003; Schmid, et al. 1999; Zhou, et al. 2005) also stimulate 
steroidogenesis and may have some role in ovary growth prior to maturation (Zhou et al. 2005). 
Regulation of the whole ovarian recrudescence process will be described in the next section. 
Other identified regulators that not yet have a defined function include, epidermal growth factor 
(EGF) receptors in the follicles, probably involved in the production of steroids and 
prostaglandins and other peptides like insulin, prolactin and GH. 
 
 
1.3.2. MOLECULAR ENDOCRINOLOGY OF THE OVARY 
Regulation of previtellogenic growth of the ovary remains largely unknown. The basis of 
endocrine mechanisms in the female gonad is described from the point when the follicle starts to 
grow significantly and to produce FSH-induced testosterone and the ovarian regulation by the 
hypothalamus and pituitary (Juengel and McNatty 2005). In the oocytes, FSH stimulates the 
synthesis of the yolk vesicles (Wallace and Selman 1981). Testosterone will be catalyzed into 
17β-estradiol (E2) by aromatase P450 at the follicle. E2 will be transported to the liver where it 
will stimulate hepatic segregation of VTGs (refs) and also of oocyte membrane proteins 
(Nagahama et al, 1993). These will be transported back to the ovary where it is selectively 
incorporated in the oocytes in a process mediated by receptors. Prior to maturation, E2 levels 
decline and maturation-inducing hormone (MIH) levels rise, due to possible dramatic changes in 
expression of their genes (Nagahama et al. 1993). It is unclear how this sudden change in the 
steroidogenic pathway occurs, but it may be that GTHs downregulates aromatase activity and 
upregulates the enzyme that will catalyze the specific MIH, 20β-hydroxysteroid dehydrogenase 
or 20β-HSD (Senthilkumaran, et al. 2002; Zhou et al. 2005). MIH is progesterone in all 
vertebrates, but not in fish where it is 17α-20β-dihydroxy 4-pregnen-3-one (Nagahama et al. 
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1993), or 17α,20β,21-trihydroxy-4-pregnen-3-one (Rocha and Reis-Henriques 1998). The 17α-
20β-DP MIH is formed from 17α-P (synthesized by 20β-HSD) in theca cells by LH stimulation 
(Senthilkumaran et al. 2002), and then diffuses to the granulosa cells, where is in contact with the 
oocyte surface. Early studies in tilapia suggest deoxycortisone to be their MIH (Coward and 
Bromage 2000). MIH binds to receptors at the surface of the oocyte membrane and a maturation 
promoting factor (MPF) is formed, which will mediate MIH (Bentley 1998). This is achieved by 
the stimulating action of MIH on cell division cycle (Cdc25) phosphatase, an enzyme that 
dephosphorylates some of the aminoacid residues of MPF, activating it (Bhattacharya, et al. 
2007). In carp it has been isolated a MPF consisting of two components, a homolog of the cdc2+ 
gene of yeast (p34cdc2) and cyclin B. A cdc2 kinase protein is the catalytic component, present in 
both mature and immature oocytes and cyclin B (the regulatory component) only found in mature 
ones. Cyclin B has been shown to possess a crucial role in 17α-20β-DP-induced oocyte 
maturation (Bhattacharya et al. 2007; Nagahama et al. 1993; Rocha and Reis-Henriques 1998), 
being the regulatory component of the dimeric protein kinase complex MPF. MIH also releases 
oocytes from the meiotic arrest that happens at the end of Prophase I. GVBD is a final marker of 
oocyte maturation which is catalyzed by MIH (Bhattacharya et al. 2007; Goetz and Garczynski 
1997) or GnRH (Cardinali et al. 2004) and thus affected by MPF (Bhattacharya et al. 2007). 
Finally, ovulation is considered to be some kind of inflammatory reaction, with possible 
regulators being eicosanoids, catecholamines, kinins, angiotensin, histamine (Goetz and 
Garczynski 1997), proteases and their inhibitors (Coward and Bromage 2000). Prostaglandins 
and progestational steroids may be necessary, as shown in some species like brook trout 
(Salvelinus fontinalis) and yellow perch (Perca flavescens), being synthesized by steroids and 
possibly involving follicle and extra-follicular tissue. Hormone-dependent ovulation requires 
protein kinase C (PKC) activation of MIH that will in turn bind to nuclear receptors (nMIH-R) 
and initiate transcription of ovulation inducers (fig.4). 
Prior to folliculogenesis and during its early stages, there are not necessarily GTH 
dependent development processes. In these cases there are local factors being expressed 
(Drummond 2005; Pangas and Rajkovic 2006). In fact, for the follicle to respond to GTHs, it first 
needs to gain the capacity to incorporate them, meaning, a receptor and the postreceptor signal 
transduction systems. These factors and others have now a bigger chance of being discovered and 
what their function is with genetics and molecular and cellular biology techniques. One area of 
interest is the sex determining/differentiation genes like FoxL2 and others (Shirak et al. 2006). 
The other revolves around follicle growth and its regulations by various signalling factors. One of 
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the major families known is the TGF-β superfamily (Drummond 2005; Lerch et al. 2007), being 
one of its key members activin, responsible for early formation of the follicles (Jaatinen, et al. 
2002). Activin (fig. 5) regulates FSH synthesis, potentiates its actions by increasing receptor 
expression in granulosa cells, is thus responsible for the formation of early follicles and is a 
model for a receptor system for other members of this family, like Growth Differentiation Factors 
(GDFs) (Juengel, et al. 2004; Knight and Glister 2003) and the Bone Morphogenetic Proteins 
(BMPs) (Drummond 2005; Findlay et al. 2002; Lerch et al. 2007). 
 
 
 
Fig. 5 – Regulation of activin signalling (Source: Lerch et al. 2007). Activin signal via type I and II receptors, 
propagating the signal in the pituitary intracellularly via Smads, which interacting with transcription factor Pitx2 (co-
activator) stimulate FSH. The latter travels in the blood stream to the ovary and interacts with the granulosa cells of 
the follicle, binding to its receptor. FSH will then induce inhibin and follistatin, the later inhibiting locally activin, 
decreasing its activity. The dominant hormone becomes inhibin, which is sent in the blood stream to the pituitary, 
where it inhibits activin signalling.   
 
 
 For this thesis, the gene expression of some other putative factors obtained from a 
suppression subtractive hybridization was to be analysed. With that aim, some genes were tested 
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for mRNA expression throughout oogenesis: Vasa, FoxL2 and CYP19a as controls, BMP-R IB, 
RBMX, CPI-17, Aly protein and some others with unconfirmed identity (SART, PPMP protein, 
XP2 and clone 26).  
 
 
1.4. OBJECTIVES 
The main objectives of this work were to analyse expression of factors participating on the 
regulation of the ovary of Oreochromis mossambicus, by mRNA expression analysis of 
several genes encoding for known molecules, some with a known function (at least partially) 
and others with possible roles in ovary maintenance, or for some obtained sequences that 
might represent new genes or alternative transcripts of the known ones, but not with any 
known function. The genes tested were obtained by suppressive subtractive hybridization. The 
expression patterns represent each gene’s expression throughout oocyte growth, revealing 
when they are most important in the process and suggesting an inference on which function 
they might execute. As further work the full sequences of these genes would be obtained by 
means of RACE-PCR.  
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2. MATERIAL AND METHODS 
For the characterization of the expression patterns of the various genes studied, several 
methods of molecular biology were used, with bioinformatics being employed when necessary. 
These were employed in order to obtain RNA transcripts of each stage of oocyte development, to 
construct the respective cDNA for these tissues and quantify the expression of each of the genes 
in each stage for a total of 8 females used as replicates. Reagents used are described in annex I 
and cloning procedures for sequencing are detailed in annex V.  
 
2.1. BIOLOGICAL MATERIAL AND SAMPLING 
Females were selected from families maintained in 200 L fresh water aquariums at 27ºC, 
12 hour photoperiod, constant oxygenation and sand on the bottom. There were 4 females and 
one male for each aquarium, which were fed daily with commercial cichlid ration. The eggs were 
collected from the female’s mouths and accounted for viable or unviable, to infer on each 
female’s fertility status. Inter-ovulation periods were monitored like this, becoming possible to 
infer on the relative time of the ovarian cycle at which the female would be at, and collect an 
ovary at a specific time of ovarian recrudescence. 8 females were killed and their ovary retrieved 
with lengths and weights registered, both for the fish and gonad, with gonadosomatic index (GSI) 
determined as in table 1 to give an idea on the healthiness of the ovary. The ovary was put into 
0,9% NaCl until the end of dissection and oocyte separation. The oocytes were separated under a 
binocular microscope, into 4 different stages of oocyte growth: oogonia (OO), primary oocytes 
(PO), early vitellogenic oocytes (EV) and late vitellogenic oocytes or mature oocytes (LV/M), 
depending on the state of development of the follicles containing oocytes for each female. Each 
sample consisted in 80 to 100 cells, or more when cell size was too small like with oogonia, to 
ensure enough mRNA. Every oocyte collected was measured for smaller and larger diameter (fig. 
6). The tissues were frozen in liquid nitrogen and put at -80ºC. Samples were also collected for 
histology, being kept in Bouin. 
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Table 1 – Lengths and weights for the 8 females used for RT-PCR, with condition factor GSI. 
Female TL* (cm) SL** (cm)
Weight 
(g) 
Ovary weight 
(g) 
GSI*** 
(%) 
            
6 16.6 13.9 75.8 2.72 3.588 
8 16.6 13 62.4 0.132 0.212 
10 16.7 4.6 60.8 0.8 1.316 
11 16 12.5 72.8 4.3 5.907 
12 17.1 13.5 75 0.93 1.240 
13 16.6 13 62.4 0.132 0.212 
14 16.5 13.1 68.8 0.53 0.770 
15 15.2 12.1 65.6 3.958 6.034 
   *Total length; **Standard length; ***GSI = Ovary weight / Total weight. 
 
 
 
 
Fig. 6 – a) Oocytes in 0,9%NaCl solution, during the oocyte collection under a binocular magnifier, with 1) oogonia, 
2) primary oocytes, 3) early vitellogenic and 4) late vitellogenic or mature oocytes and  b) diameters of oocytes for 
all females dissected (average for all oocytes in each group per female). F5, F6 and F7 were at the beginning of the 
reproductive cycle; F9, F10, F11 and F3 were at the middle of it and F1, F2, F4 and F8 were at end of the cycle. 
Kruskal-Wallis One Way ANOVA on ranks reveals a significant difference among stages (P ≤ 0,001) and Tukey’s 
test for comparison between groups show no significant differences for pairs SS-S; S-M and M-L for P < 0,05. The 
stages can therefore be considered significantly different from each others. 
4 
3 
2 
1 
a) 
b) 
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2.2. HISTOLOGY 
To identify and verify the stages of oocyte growth, the tissues were stained with 
haematoxilin-eosin coloration. The follicles were kept in Bouin for 10 days, processed in a Leica 
TP1020 overnight and they were then put into paraffin. The cuts performed were of 0,5 µm. The 
sections were first hydrated by immersion in xilol 2x during 15 minutes, then 5 minutes through 
graded ethanols (100%, 95% and 70%) and finally in distilled water. These sections were placed 
30 seconds in haematoxylin before passing them on running water and then again in distilled 
water. Next they were immersed in Eosin for 30 seconds, followed by distilled water with a few 
drops of acetic acid. Finally the tissues were again dehydrated through graded ethanols (70, 95 
and 100%) during 5 minutes each and then 2x 15 minutes in xilol. The preparations were 
mounted with DPX.  
 
2.3. RNA EXTRACTION AND CDNA SYNTHESIS 
RNAs are sensitive molecules that are easily degraded. To study tissue expression the 
RNA needs to be reverse-transcribed into the more stable molecule of cDNA by a specific 
enzyme that synthesizes double-stranded DNA, a reverse transcriptase. The RNA was extracted 
from the pools of 80-100 oocytes using Sigma’s TRI Reagent. The tissues were homogenised in 1 
ml of TRI Reagent for a weight inferior to 100 mg. Samples were centrifuged at 13,400 rpm for 
10 minutes at 4ºC. After they were left at room temperature for 5 minutes and 0,2 ml of 
chloroform were added to each tube, being then shaken vigorously for 15 seconds. Samples were 
left at room temperature for 15 minutes and then centrifuged at 13,400 rpm during 15 minutes at 
4ºC. The colourless upper aqueous phase was transferred to a fresh tube and 0,5 ml of 
isopropanol was put into each one. Samples were left at -20ºC overnight to allow a more efficient 
RNA precipitation. Following this, the samples were centrifuged for 10 minutes at 13,400 rpm, 
4ºC. The supernatant was then removed and the pellet formed washed with 1 ml of 75% ethanol. 
Samples were shaken and centrifuged at 7,600 rpm for 5 minutes at 4ºC. Finally the pellets were 
left to dry on ice and suspended on diethylpyrocarbonate-treated water (30 µl for less 
concentrated samples and 50 µl for more concentrated ones). Prior to cDNA synthesis the 
suspended RNA was treated with rDNAse I using Ambion’s DNA-free Kit, to ensure no genomic 
DNA contamination (annex IV). Taking into account a certain amount of RNA with 
concentration determined by directly observation of intensity in the agarose gel for each sample, 
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the quantities to be used in the reaction were chosen. To the volume of RNA used, up to 44 µl of 
DEPC-treated water were added, and then the final 6 µL for the total of 50 µl per sample 
consisted of 5 µl of rDNAse I Buffer and 1 µl of the enzyme rDNAse I. The samples remained 30 
minutes at 37ºC, after which the DNAse was inhibited with 5 µl of the inactivator. After 
centrifuging the inactivator was discarded to retrieve the purified RNA. 3 µg of this purified 
RNA was used for the cDNA synthesis. For each sample, in a total volume of 40 µl, up to 29,6 µl 
were of suspended RNA in DEPC water and 10,4 µl of reagents mix, with volumes of RNA 
being chosen by determining the relative quantity (ng) in 1 µl of RNA by observation of  the 
electrophoresis gel. The RNA would be put at 65ºC for 10 minutes to denaturate. The reagents 
mix prepared contained the final 10,4 µl of volume left to complete the reaction. These consisted 
of 8 µl of 5x RT Buffer, 1 µl of dNTPs at 10 mM each, 1 µl of random hexamers (pdN6) at 1 
µg/µl, 0,2 µl of RNAse guard and finally 0,2 µl of the reverse trancriptase M-MLV from 
Promega (200 µg/µl). Before adding the reagents mix, the tubes were put into ice for 5 minutes 
and then briefly centrifuged. The reaction worked for 2 hours at 37ºC and the oocytes’ cDNAs 
were finally synthesized. 
 
 
2.4. SEMI-QUANTITATIVE RT-PCR 
PCR (Polymerase Chain Reaction) allows the amplification of a gene fragment 
exponentially, using a pair of specific primers for the fragment to be amplified and a DNA 
polymerase enzyme. These primers need to be designed from a known sequence, and one of them 
corresponds to the beginning of the sequence to be amplified, called the forward or sense primer, 
and the other one from the end of the sequence, that anneals with the complementary DNA strand 
(called the reverse or anti-sense primer). The PCR consists of a first step of denaturation, in 
which the two chains are split and the DNA becomes single stranded and the primers can now 
anneal to the complementary sequences. The step of annealing depends on the cDNA being used 
and the specificity of the primer, so the majority of the times it is needed an optimization of the 
PCR conditions to be employed. For this optimization there are essentially two factors that need 
to be played with. One is the annealing temperature, that although is indicated in the primer 
description of the manufacturer, it is not necessarily the right temperature to be used with our 
sample. The second factor is the concentration of magnesium (used here in the form of MgCl2 at 
50 mM) that is used in the reaction. Magnesium helps the DNA polymerase to synthesize the 
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strands, so in principle if more Mg is added, the polymerase will bind the substrate more easily, 
and with the lost in specificity there may be more unwanted fragments amplified. If Mg 
quantities used are lower, the polymerase specificity to the DNA is higher, it becomes more 
sensitive, and there is a greater chance of obtaining the pretended fragment. This optimization 
step is mostly required when quantifying gene expression, as more than one fragment as the PCR 
product means a loss of primers that are binding to unwanted fragments. If this happens 
quantification will be biased. The third step is elongation, in which the polymerase synthesizes 
the new complementary strand for each of the obtained denatured strands. This three steps are 
then repeated the necessary amount of times for the product at least be visible on an agarose gel 
by electrophoresis. For this study it was also necessary to quantify the expression at the several 
stages of oocyte growth (by semi-quantitative PCR, as the quantification was done relatively, 
comparing the intensity of the products with a reference gene that should be expressed in all 
tissues equally for normalization – rRNA 18S).    
 
       Table 2 – List of primers used for RT-PCR and RACE-PCR, with conditions employed for each set. 
 
*BMP-R IB, RBMX, CPI-17, and Aly protein primers were at a concentration of 20 pmol / ml. All others were at 10 pmol / ml. 
Gene     Primer sequences Melting  MgCl2 
                temperature (ºC) (mM) 
Nr of cycles
 RT-PCR*          
Vasa  Fw 5'- GAT TTG GCA GAA CGG ATC ACA GTA -3' 
  Rv 5'- GTG GTT CTA GAG TAG CAT GAA CAG -3' 
58 3 30 
FoxL2  Fw 5'- GTT CCC AGT ATG AGC AGT GCA -3' 
  Rv 5'-  GTG GGT GAG GCT ACA GGA TGT GTA -3' 59 3 28 
CYP19a  Fw 5’ - GGC ATA GGC ACA GCC AGC AA - 3’  
  Rv 5’- GGT CCA CTC GGA CAT ACC TCC T  - 3’ 
60 3 32 
BMP-R IB  Fw 5’- CTT GTT GAT TTC AGT CAC TGT ATG CA -3’ 
  Rv 5’- CTC TCA GAT AAG TGC AGA GCC A -3’ 
60 1,5 39 
RBMX  Fw 5’- GAG ACT ACT ATG ATT CAG GAA GTG TA -3’
  Rv 5’- ATA ATC ATC CCT TCT GGA CAT CAT CG -3’ 
57 3 32 
SART  Fw 5'- TCT GCA CAC TCA GAG ATG TTT CTA C -3' 
  Rv 5'- TTA TGA CAG GAG TAA GGC CAC TGT T -3' 58 3 30 
PPMP protein  Fw 5'- GTG GTA TTT TTT AGG TAT GGA TCT CAT -3' 
  Rv 5'- ACA CCT ACC TCT CTT ACC TCA AAC AC -3' 
58 3 31 
CPI-17  Fw 5’- ACA TTG ATG ATT TGC TCG ACC T -3’ 
  Rv 5’- CTG ATT TTG CTC TTG GGT GTG GTG A -3’ 
57 3 26 
XP2  Fw 5'- GGC GCT ACG GAC ACT TCA AGC A -3' 
  Rv 5'- TGA TGT CAG AGC TTC GTG CTC TGT -3' 60 1,5 32 
Clone 26  Fw 5'- AAG AGA ACC TAA CAC ACT CAT CCT AC -3' 
  Rv 5'- GTC TGA CTG CTG TCC TGT GTA TTC -3' 
58 1,5 31 
Aly protein  Fw 5’- AGG AGG AAA CAG ACC CCA GC -3’ 
  Rv 5’- GAG CGT CAT CCC ATC AGA GTC CT -3’ 
58 3 29 
 RACE-PCR          
CPI-17  Rv1 5'- TCA TCA ATG TTA ACC TCC TCT GGC AT -3'   
    Rv2 5'- GGC TGG ACG TGG AGA AGT GGA TCG -3'  
57 3 35 
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Genes studied were obtained by suppression subtractive hybridization (SSH), comparing 
the relative difference in concentration of mRNA transcripts of genes tested in ovary and testes, 
with primers for these genes being done after sequencing of products of the SSH. The primers for 
the control genes Vasa, FoxL2 and CYP19a were designed from published sequences (GenBank) 
from Oreochromis mossambicus, or when not available, from Oreochromis niloticus. They were 
constructed using an online oligonucleotide properties calculator 
(http://www.basic.northwestern.edu/biotools/oligocalc.html) having in consideration that they 
should have a GC content of around 50% and an annealing temperature between 50º and 60ºC, 
with annealing temperatures for forward and reverse primers differing no more than 5ºC. The 
fragments to be amplified should have from 100 to 450 base pairs. These primers were tested for 
preferential expression in ovary rather than testis by RT-PCR, and when positive they were 
chosen as good candidates for having some particular role in oocyte growth. RT-PCR for each set 
of primers in oocytes was done using always the same quantities in a total of 10µl per tube using 
EuroTaq DNA polymerase. Taq DNA polymerase is a thermostable enzyme isolated from the 
bacteria Thermophilus aquaticus, with a molecular weight of 94 kDa. This enzyme synthesizes 
double-stranded DNA in the direction 5’-3’ in the presence of magnesium. Reagents and 
quantities used are described on fig. 7 and annex I. PCR optimization for some genes where more 
than one band could be detected was done by changing MgCl2 concentrations (1µl of MgCl2 is 
3mM in total reaction volume of 25 µl) and annealing temperatures. These and the number of 
cycles used for amplification of each gene fragment can be seen on table 2. The optimization 
procedures also involved the determination of the adequate amount of cycles to be used in the 
PCR. Details of all these optimization procedures are described in annex II.  
 
Fig. 7 – PCR mixture of reagents used for each set of primers. After the optimization procedures, the same PCR 
procedure was used for all primers, only changing MgCl2 volumes in the mixture and the primers. The mix was done 
in an eppendorf tube of 1,5 ml and concentrations were in a total of  25 µl: 1x Taq buffer, 1 to 3 mM MgCl2, dNTPs 
at 0,2 µl each, primers at 0,4 to 0,8 pmol/µl, cDNA and water (sigma). 
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The PCRs were all run in Biorad’s myCycler thermocycler and consisted of 4 minutes of 
initial denaturation at 94ºC, followed by cycles of 25 seconds of denaturation again at 94ºC, 25 s 
of annealing with temperatures depending of primers and 35 s of 72ºC elongation step. Products 
were stored at 4ºC until run on a 3% agarose gel by electrophoresis (electrophoresis procedure is 
described in annex III). The bands were quantified using Biorad’s Quantity One software, to 
obtain the expression patterns for each gene throughout oogenesis. For the quantification, the 
bands obtained couldn’t be saturated, hence the reason why the number of cycles had to be 
optimized, to obtain the exponential phase of a PCR, and not when it is saturated and 
immeasurable. 
 
 
2.4.1. STATISTICAL ANALYSIS 
Results are presented as the mean of all 8 female’s intensities of gene expression during 
each stage of follicle development ± standard error of the mean (se). To test whether the means 
among the different groups (OO, PO, EV and LV/M) were significantly different, it was used a 
One-Way Analysis of Variance (ANOVA) followed by multiple comparison procedures among 
groups, using Tukey’s Honestly Significant Difference test or Dunn’s method. When the test for 
normality of the distributions failed, or the test for equality of variance, it was used Kruskal-
Wallis One-Way ANOVA on ranks followed by either Tukey’s or Dunn’ method for isolating the 
groups that differ from the others. Graphics were done using SigmaPlot and statistics using 
SigmaStat. Correlation between the expressions of the different genes was assessed using the 
Pearson Product Moment Correlation. Statistical significance was considered at the 5% level (P < 
0,05).  
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3. RESULTS  
Results are presented starting by a histological dye of haematoxylin-eosin to a tilapia ovary at 
mid of the reproductive cycle to show a representative view of the stages of development of each 
of the stages collected. Following this come RT-PCR results, both for the testing of sexual 
dimorphic expression of the genes analysed, and the semi-quantitative analysis in oocytes of 8 
females. Finally the Pearson Product Moment Correlation matrix shows which genes display 
correlated levels of expression. 
 
3.1. HISTOLOGY 
Haematoxylin is a base that colours acidic components of the cell (basophilic structures), 
with purple hue and alcohol-based acidic eosin, colours acidophilic (or basic) structures found in 
the cytoplasm bright pink. The basophilic structures are usually the ones containing nucleic acids 
(most abundant acidic components), such as the ribosomes, the cell nucleus, and the 
cytoplasmatic regions rich in RNA (Timm 2005). 
  
Fig. 8 – O. mossambicus ovary tissue dyed with haematoxylin-eosin. In the picture the numbers indicate the four 
stages used for analysis of expression of the genes considered: oogonia (1), primary oocytes (2), early-vitellogenic 
oocytes (3) and late-vitellogenic or already mature oocytes (4). Mature oocytes are already free of the follicle 
envelope (5), being ready to be ovulated.   
 
 From the previous description, oogonia and primary oocytes (1 and 2 respectively) 
cytoplasm seems enriched with nucleic acids and the later stages (3 and 4) seem to have more 
basic structures. So the stages used according to histology present the following stage of 
development: 
1
2
3
4 
5 
      1 mm 
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(1) Oogonia, stage prior to meiosis, differentiated from primordial germ cells where a great 
amount of RNA seems to be distributed through the cytoplasm; 
(2) Primary oocytes, with the onset of the first meiotic step also rich in mRNA already bigger 
in size; 
(3) Early vitellogenic oocytes, with follicle layer (theca and granulosa cells) clearly 
surrounding the oocyte; the oocyte is bigger with vitellogenin being gathered and mRNA 
difunded through the cytoplasm. VTGs are still accumulating in vesicles; rich in 
organelles; 
(4) Late-vitellogenic oocyte, with yolk globules already formed and fusing (maturation). No 
follicle layer is seen around the oocyte, so it is probably already mature and ready to be 
ovulated.  
(5) Ovarian follicle, with outer theca cells and inner granulosa cells next to the oocyte. 
 
3.2. SEXUAL DIMORPHIC EXPRESSION  
These results show the prior determination of differential expression by RT-PCR of 
selected genes in ovary and testes (fig. 9). The reference used was 18S. Those genes with relative 
concentration was higher in ovary were selected for analysis of differential expression throughout 
oogenesis. 
 
 
 
Fig. 9 – Each gene was tested for sexual dimorphism, using cDNA from testes and ovary, in 2 different RT-PCRs (a) 
and (b). By looking at the bands’ intensities relatively to ribosomal 18S RNA we can determine the relative 
expression for each gene. Other genes Twist-Neighbour (TN), XP1 and clones seen show sexual dimorphism but 
were not tested through oocyte growth, except for TN, XP1 and clones 15 and 30 in a prior test to the actual 
experiment, which is described in annex VI. 
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 The designation ‘clone’ indicates sequences with no homologs found. So they could be a 
new gene or an untranslated region (UTR). XP1 and 2 are hypothetical new proteins with 
unknown functions. PPMP22 and SART have a partial sequence homolog to these genes but 
aren’t necessarily so. The genes analysed revealed differential expression in ovary and testes. In 
addition FoxL2, Vasa and CYP19a were analysed to answer doubts concerning the use of rRNA 
18S as the reference and to consolidate the reliability of the technique in use.  
 
3.3. PATTERNS OF EXPRESSION THROUGHOUT OOCYTE GROWTH 
Highly expressed genes in ovary include BMP-R IB, CPI-17, Aly, XP2, PPMP22, SART 
and RBMX. Vasa served as a control gene, being a marker of germ cells and a probable good 
indicator of oocyte quantity, but literature seems to show also that it’s not expressed always in 
same quantities in all germ line cells, particularly in oocytes. Results using the 18S gene as the 
reference seem to be in accordance with patterns observed in previous works. Figure 10 shows an 
example of the gel electrophoresis where the PCR products were run for each gene. These bands 
were quantified; in this case the intensity obtained for the Vasa gene was divided by the intensity 
of the corresponding band for 18S. Electrophoresis migrations for the other genes tested can be 
seen in annex VII.  
 
Fig. 10 - Bands obtained with the DNA electrophoresis to the PCR products of the RT-PCR for reference gene 18S 
and one of the genes tested, Vasa. Each band corresponds to the intensity of expression in each stage of oocyte 
growth for the 8 females. These bands were quantified for intensity (INT), all in one same area. Quantification was 
made with Quantity-One and the intensity of the gene tested was divided by the one from 18S (Gene/18S), with 
intensities expressed in INT*mm2 and in the same areas that were only different for each gene, but the same for all 
females and stages. For similar images on the remaining tested genes see annex VII.  
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3.3.1. Vasa 
Vasa is expressed only in germ line cells, thus it was considered using it as reference 
instead of 18S. However, literature seems to suggest a difference in vasa mRNA in different 
stages of oocytes. Its expression pattern shows a higher degree of expression during both 
previtellogenic stages tested. 
  
Fig. 11 – Vasa expression pattern during oocyte growth. The quantities are expressed in arbitrary units, being 
obtained using 18S as a reference (Gene/18S), with each being measured as INT*mm2. The results represent 
averages of each stage for all 8 females with standard errors (mean ± se). Statistical analysis was done with One Way 
ANOVA, showing a significant difference that the mean values among the treatment groups are greater than would 
be expected by chance (P <0.001). Tukey method of All Pairwise Multiple Comparison Procedures revealed 
similarities and differences among particular stages (P < 0,05). The characters on top of the bars, if identical, mean 
there is no significant difference among those stages. 
 
 
 Oogonia and primary oocytes revealed greater quantities of Vasa mRNA, showing no 
significant statistical difference (a). Early and late vitellogenic oocytes show a decrease in 
expression, and difference among these is not significant either (b).  
 
 
3.3.2. FoxL2  
The putative transcription factor FoxL2 has never been detected in the oocytes, only in 
granulosa cells of the follicle. FoxL2 is the earliest known sexual dimorphic marker (Cocquet, et 
al. 2002; Pannetier et al. 2006). Here, expression was found in all stages of oocytes tested, with 
an increase towards the later stages. 
 
27
 
Fig. 12 – FoxL2 expression increased throughout growth of the oocytes. Kruskal-Wallis One Way ANOVA on ranks 
was carried, as the distributions failed the normality test. The groups showed a statistically significant difference (P = 
0,005). Multiple comparisons were made with Dunn’s test, and differences between groups are indicated as above (P 
< 0,05). When 2 groups, like oogonia and primary oocytes in this case, don’t have any significant difference between 
means, they can’t be compared and thus aren’t tested. However, in these cases, expression is clear to be similar and 
thus doesn’t need to be made a comparison. In the following results the same can be apllied. 
 
 FoxL2 expression is clearly higher in later oocytes. If some kind of relationship could be 
established between this and the aromatase gene, and those results were in accordance with 
previous publications, it would be reinforced the use of 18S as the reference gene. 
 
3.3.3. CYP19a 
The gene that codes the last enzyme in the conversion of testosterone to 17β-estradiol is 
CYP19a. This gene is usually denominated tCYP19a, t for tilapia, a for designating the ovarian 
type of aromatase P450. 
 
Fig. 13 – The coding gene for the aromatase enzyme, CYP19a (ovarian type) shows a rise in expression through the 
process. Kruskal-Wallis One Way analysis of variance shows there is difference among the stages (P < 0,001). 
Dunn’s method for differences among group means is shown as previously (P < 0,05).  
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 CYP19a expression is similar to the expression pattern for FoxL2, and previous works on 
these genes shows the latter to regulate transcription of aromP450. While this isn’t entirely new 
data, it may be a way of showing 18S might be used as the reference gene with a less significant 
error, as the results obtained here are similar to those obtained by others, with different and 
similar techniques. 
 
 
 
 
3.3.4. RBMX 
RBMX stands for RNA-binding motif on the X chromosome and is involved in splicing 
(it can also be called hnRNPG for heterogenous nuclear ribonucleoprotein). RBMX is also 
expressed in testes, but much more expressed in ovary. These results show a decrease in 
expression towards the end of oogenesis, in the vitellogenic stages of oocyte development. 
 
Fig. 14 – RBMX showed a decrease in expression. Groups are significantly different (One Way ANOVA), P = 
0,005. Tukey method shows some similarity among early and late vitellogenic oocytes, and also between the first 
and previtellogenic oocytes (P < 0,05).  
 
 
3.3.5.  ALY PROTEIN 
This protein has a domain common to the Aly family (metazoans’ equivalent of the REF 
family in yeast), and shows a slightly higher expression in ovary than testes. 
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Fig. 15 – The Aly family protein didn’t show strong variation, but there is room for a putative role in the cell 
machinery. Kruskal-Wallis One Way ANOVA showed no significant difference in means (P = 0,381). 
  
The gene didn’t show a significant difference among group means and there is one Aly 
protein that has recently been attributed function as mRNA exporter from the nucleus.  
 
3.3.6. BMP-R IB 
The bone morphogenetic proteins receptor IB was tested, as it has a possible prominent 
role as shown by other TGF-β superfamily members. 
 
Fig. 16 – Bone morphogenetic protein receptor, type IB expression. There was a significant difference among means, 
revealed by Kruskal-Wallis One Way ANOVA (P < 0,001). Comparison’s between stages by Dunn’s method (P < 
0,05) reveals similarity in both previtellogenic stages, and between primary oocytes and late vitellogenic oocytes. 
 
 Pattern shows an increasing expression in vitellogenic stages.  
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3.3.7. CPI-17 
CPI-17 is a 147 residue inhibitory protein of protein phosphatases 1 (PP1), with 17 kDa, 
potentiated by PKC (Walsh, et al. 2007). Expression was detected in the ovary, and after sexual 
dimorphic expression was confirmed, it was tested on the growing oocytes. 
 
Fig. 17 – CPI-17 quantification shows CPI-17’s inhibitory action to decrease through the cycle. One Way ANOVA 
failed normality so it was conducted a Kruskal-Wallis test that showed a significant difference (P < 0,001). The 
following Tukey test for comparisons between groups shows a clear distinction along oogenesis in expression, with 
primary oocytes and early vitellogenic still exhibiting a relative similarity (b) (P < 0,05).  
 
 The results suggest a particular importance of this in the earlier stages or at least a higher 
expression of the gene. RACE-PCR was to be done for full sequencing and confirmation of its 
identity as a CPI-17 homolog (annex IX).  
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3.3.8. SART and PPMP protein 
This sequence needs full sequencing for confirmation of a SART homolog, as well as the 
protein with the PPMP motif. 
  
Fig. 18 – i) Expression pattern for the homologue sequence to the SART gene, not showing a significant difference 
(P = 0,586) and ii) Expression of the homolog sequence to the motif PPMP. One Way analysis of variance (P 
<0,001) reveals significant difference among groups. Tukey’s test shows similarity between both previtellogenic 
stages (a) and the two vitellogenic stages (b) tested (P < 0,05). 
3.3.9. XP2 and clone 26 
XP2 sequence doesn’t correspond to any known sequence, and so it has been identified as 
a putative protein XP2. In differential analysis between ovary and testes, it was found a much 
higher expression in the ovary, thus it was tested in the oocytes.   
          
Fig. 19 – i) Expression of the hypothetical protein denominated XP2, shows an interesting result, with One Way 
ANOVA revealing significant difference between means (P < 0,001). Tukey test (P < 0,05) reveals more similarity 
among pre-vitellogenic stages (a) and then between the vitellogenic ones (b). ii) Clone 26 showed a decrease in 
expression, indicating a possible decisive regulating molecule during oocyte growth. One Way ANOVA indicates 
significant difference among groups, with P = 0,001. Tukey’s method for multiple comparisons between each of the 
groups suggests a dissipating action along the cycle, showing stronger expression in the early stages (P < 0,05).   
ii) 
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 While it is obvious that there is a decrease in expression in vitellogenic stages, the 
unidentified protein cannot be attributed a role without further studies on its structure, actions and 
expression along other tissues. But it may be a good subject to study not only in oocyte 
expression through oogenesis. There is no homolog sequence in archives that resembles the 
fragment for clone 26, but it was tested nonetheless. It can be an alternative transcript of some 
other genes in the subtractive hybridization, or it can be a whole new protein or just UTR. To 
address its identity further work is required, to know the full sequence of a putative gene.  
  
 
Finally, statistics of correlations among genes are presented in table 3. 
 
 
Table 3 – Pearson Product Moment Correlation for comparison of expression patterns between genes (P < 0,05). The 
empty cases are for a pair of genes which didn’t show correlation as P > 0,05. When there is a significant correlation: 
+ indicates pairs of values that tend to increase together and; - indicates a correlation, but while one’s values 
decrease, the other gene values increase. 
 
Correlation    BMP-R IB FoxL2 CPI-17 RBMX Vasa XP2 Aly SART PPMP Clone 26 
Coefficient for:                       
            
CYP19a  + + - - - -   - - 
            
BMP-R IB   +       -  
            
FoxL2      -    -  
            
CPI-17      + +   + + 
            
RBMX      + + + + + + 
            
Vasa       + + + + + 
            
XP2        + + + + 
            
Aly         + + + 
            
SART          + + 
            
PPMP           + 
                        
 
For details on correlation coefficients, P-values and n values see annex VIII. A summary 
of the results can be seen in figure 20. 
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Fig. 20 – Summary of possibilities for the various genes tested along oocyte development. Areas represent intensities 
in expression throughout the process. In (1) Vasa is highly expressed and decreases towards the later stages. FoxL2, 
CYP-19 and BMP-R IB are all more expressed in 3 and 4 and are positively correlated. CPI-17 and RBMX seem to 
have a more distinctive role in pre-vitellogenesis (1 and 2) processes. Aly protein expression seems to be constant 
from 1 to 4. Of the other genes tested, SART remained constant and XP2, clone 26 and PPMP also decreased from 1 
to 4. Genes with decreasing patterns must act mainly in cellular differentiation processes, genes with increasing 
expression probably act mainly at maturation processes, while a constant expression suggests a basic essential 
cellular function or control mechanism. 
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4. DISCUSSION 
The use of rRNA 18S as a reference was questioned, as there are reasons to believe they 
might accumulate in the growing oocytes (Kaplan, et al. 1982; Malewska and Olszanska 1999; 
Van den Eynde, et al. 1989). This uncertainty was considered, as prior to the actual experiment, a 
test was conducted to a female 0, with 3 sizes of oocytes collected and all of the tested genes 
expression was decreasing (annex VI). For this reason expression of genes Vasa, FoxL2 and 
CYP19a was also analysed as they have been previously studied and results, if similar, could 
prove the reliability of using rRNA 18S as the reference gene. Another possible candidate for 
reference gene would be elongation factor 1α (Bobe et al. 2006).  
The vasa-like gene encodes an ATP-dependent RNA helicase protein which belongs to 
the DEAD-box family and plays key roles in germ-cell formation in higher metazoans (Braat, et 
al. 1999a; Braat, et al. 2000; Cardinali et al. 2004; Knaut, et al. 2000; Raz 2000; Ye, et al. 2007). 
In ovary it’s limited to germ cells and is expressed throughout oogenesis, but intensity and sub 
cellular distribution differs greatly at each of the different stages according to Wolke, et al. 2002; 
Xu, et al. 2005 and Ye et al. 2007. It’s essential for PGC formation and their migration to the 
germinal ridge (Ye et al. 2007). Vasa is a germ cell marker in animals (proved with zebrafish) 
(Wolke et al. 2002; Ye et al. 2007). The expression pattern with RT-PCR shows a high level of 
expression in oogonia and primary oocytes (fig. 11). Vasa expression in oogonia was the highest 
with primary oocytes following close by, showing no significant difference with Tukey test. This 
information is consistent with what was observed by Ye et al. 2007), who detected Vasa 
expression in rice field eel (Monopterus albus), in zebrafish or Danio rerio (Braat, et al. 1999b) 
and in the Nile tilapia by Kobayashi, et al. 2000), with great intensity at the oogonia and early 
oocyte stages, throughout the cytoplasm. As oocytes grew the signal became weaker in 
vitellogenic oocytes and even more in post-vitellogenic ones. This was also observed in the 
present work; a decrease in early vitellogenesis and low expression in late vitellogenic/mature 
oocytes. In early vitellogenesis, vasa expression decreases, indicating a possible decrease in 
function during this stage and until maturation, where expression is even lower. In mid-
vitellogenesis vasa signal moves to the perinuclear cytoplasm according to (Cardinali et al. 2004; 
Xu et al. 2005), and further on the signal gets weak, possibly due to decreased expression or 
dispersion through the larger volume and moving between yolk vesicles (Xu et al. 2005). It has 
been detected a peak at the beginning of vitellogenesis by (Knaut et al. 2000) although in this 
work, no peak was found at this stage. If the results by (Knaut et al. 2000; Xu et al. 2005) are 
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right, maybe it’s indicative of the oocytes collected in our work to be already deeper into the 
process rather than the early-vitellogenic status given to them.  
The Forkhead family of transcription factors is involved in cellular differentiation and 
proliferation. FoxL2 is a putative transcription factor of this family exhibiting tissue specific 
distribution, being also involved in ovarian development and function thus essential for proper 
female reproductive function (Baron et al. 2004; Cocquet et al. 2002; Ottolenghi et al. 2005; 
Ottolenghi, et al. 2007; Pannetier et al. 2006; Pisarska et al. 2004; Uhlenhaut and Treier 2006; 
Wang et al. 2004). It can interact with GnRH receptor in the pituitary to regulate its expression 
and it’s expressed also in brain, pituitary, gill of tilapia (Wang et al. 2004) and in the granulosa 
cells surrounding the oocytes (Baron et al. 2004). Other known target genes besides GnRHR are 
the steroidogenic acute regulatory gene (StAR) in adult ovary (Pannetier et al. 2006; Uhlenhaut 
and Treier 2006) and CYP19a in the follicle, one of the genes tested. Expression has never been 
detected in oocytes according to literature (Baron et al. 2004). In this work, expression was 
detected in all stages of follicle collected (fig. 12). In oogonia and primary oocytes expression is 
lower (around half), with no significant difference among their means. FoxL2 has been 
referenced as a sex differentiation gene, so maybe there is still some mRNA from after PGC 
differentiation into oogonia. FoxL2 also has basic cellular functions so they may have some 
function in regulation of oocyte growth. In early vitellogenesis FoxL2 mRNA starts rising, with 
its peak happening at the late vitellogenic/mature oocytes. This surge may be related to CYP19a 
transcription, which has been shown in several animals as correlations were made for chicken and 
rainbow trout aromatase (Pannetier et al., 2006), and also the Nile tilapia (Wang et al. 2007). This 
author suggests that FoxL2 binds to the sequence ACAAATA in the promoter region of CYP19a 
(in vitro) through its forkhead domain and activates CYP19a transcription with its C terminus. 
Furthermore its expression positively correlated with CYP19a expression. That positive 
correlation was also observed in our results, with correlation coefficient being positive, thus 
showing a relationship where they tend to increase together along oogenesis (table 3). CYP19a 
encodes the aromatase P450 that catalyzes estrogen production from androgen (Kazeto and Trant 
2005; van Nes, et al. 2005; Wang et al. 2007), particularly the synthesis of 17β-estradiol from 
testosterone in the theca cells of the follicle, stimulated by FSH or LH in some species (Yoshiura, 
et al. 2003). Two aromatase genes have been identified in fish: CYP19a and CYP19b, the first for 
the ovarian type (due to high expression in vitellogenic ovaries, Tchoudakova, et al. 2001) and 
the latter for brain aromatase. FoxL2 might be interacting aromatase transcription, maybe 
activating it. CYP19a promoter region contains AdBP/SF-1 ligand-binding domain (member of 
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the orphan nuclear receptor protein) (Yoshiura et al. 2003) showing this may be a transcriptional 
regulator, although there are no differences in males and females during early sex differentiation. 
Ad4BP/SF-1 can interact with the forkhead domain of FoxL2, forming a heterodimer and 
enhance CYP19a transcription (Wang et al. 2007). Pannetier et al. 2006 also refers a possible role 
for activin-βa as the co-factor. Expression obtained for aromatase shows, as in FoxL2, a great 
increase at the two later stages (fig. 13). During vitellogenesis it’s being more expressed to 
synthesize T into E2, which will travel in the bloodstream to the liver where it will induce VTG 
synthesis that will be incorporated by oocytes. In later vitellogenesis these values get even higher. 
Some of these oocytes were still at a late vitellogenic stage, and some were mature, depending on 
the females dissected and their stage in the cycle. Thus, at this stage, besides E2 synthesis, 
aromatase may be catalyzing MIH synthesis, as it will be required for oocyte maturation 
(Yoshiura et al. 2003).  
 
 
RBMX 
RBMX stands for RNA-binding motif on the X chromosome (it can also be called 
hnRNPG or heterogenous nuclear ribonucleoprotein G) involved in splicing (Martinez-Arribas, et 
al. 2006; Takemoto, et al. 2007). In contrast to RBMY, the Y chromosome homolog with specific 
expression in testes, RBMX has a widespread expression pattern, suggesting its expression on 
general developmental processes (Elliott 2004), with particular importance in the brain and liver 
(Takemoto et al. 2007; Tsend-Ayush, et al. 2005). RBMX also can be found in the way of 
retrotransposed copies in the genome, which lack introns and are thought to be a result of the 
insertion of processed cDNA, denominated RBMXLs (Elliott 2004; Lingenfelter, et al. 2001; 
Takemoto et al. 2007). These retrogenes are derived from the X chromosome transcripts and 
might be particularly important when transcription is inactivated due to chromosome 
condensation for example. Sequences for RBMX and RBMXLs are remarkably conserved, 
suggesting they arose before primate divergence. As they are nuclear proteins, it is thought that 
they regulate RNA processing or splicing, which happens at the spliceosome, a complex of 
ribonucleoproteins (Elliott 2004). RBMX has been detected in zebrafish with a 77% identity to 
human RBMX (Tsend-Ayush et al. 2005), and now in tilapia. Expression in oogonia was highest, 
decreasing towards mature oocytes (fig. 14). The higher levels of mRNA transcripted in earlier 
steps of oogenesis might be indicative of its involvement in splicing. In the oogonia and primary 
oocytes, the cytoplasm is rich in RNA (see fig.8), thus RBMX might be necessary for splicing of 
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a higher quantity of RNA and therefore be more expressed. In vitellogenic stages the oocyte 
grows, and it seems gene transcription is not so abundant. This and the basic organelles in the 
oocyte turn the latter bright pink in haematoxylin-eosin dye. RBMX revealed to be positively 
correlated to Aly, a putative mRNA exporter.   
 
 
Aly 
Aly proteins also belong to the superfamily of RNA binding proteins with 
ribonucleoprotein-type RNA binding domains, being the counterpart in metazoans of a known 
nuclear export factor in yeast (REF), which is probably conserved even in mammals (Longman, 
et al. 2003; Luo and Reed 1999; Suganuma, et al. 2005; Zhou, et al. 2000). The difference with 
other hnRNPs like RBMX consists in the presence of two highly conserved motifs at the N and C 
termini (Rodrigues, et al. 2001). Aly connects the splicing of pre-messenger RNA in the cell 
nucleus with the export of spliced messenger RNA to the cytoplasm (fig. 21).  
 
Fig. 21 – Mechanism of Aly exportation of RNA from nucleus to cytoplasm (Source: Zhou et al. 2000). Aly is 
recruited to the spliceosome, a dynamic complex of proteins in the nucleus that splices pre-messenger RNA. The 
spliceosome splices together the exons into a messenger RNA protein complex called the mRNP. Aly tightly 
associates with this mRNP and probably only exports the rightly synthesized mRNA molecules. The Aly-mRNP 
complex is then exported to the cytoplasm, the mRNA is translated into a protein, and Aly is redirected to the 
nucleus (Kim and Dreyfuss 2001; Zhou et al. 2000).  
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The results obtained show no significant variation among the four stages of oocyte growth 
(fig. 15), revealing that the RT-PCR fragment is from an Aly protein with this same function and 
perhaps because of its recycling to the nucleus (Zhou et al. 2000), expression along oogenesis 
proved always similar, with no significant differences among stages. Suganuma et al. 2005 also 
refers that they may act as a transcriptional coactivator. Pearson correlation is positive for RBMX 
and Aly. This suggests involvement of RBMX in the actions of Aly. The differences in a more 
stable pattern for Aly, reside in the difference that the this factor seems to be recycled to the 
nucleus, therefore, its expression might occur always at the same rate.  
 
 
BMP-R IB 
BMPs (Bone Morphogenetic Proteins) are members of the transforming growth factor β 
(TGF- β) family of growth factors. This family has gained special relevance recently, due to its 
possible major implication in ovarian related processes. Activin has been described as the 
responsible for cell reconnaissance to FSH (GTH I) in the follicle (Knight 1996; Welt, et al. 
2002). Other members such as BMPs, have been also identified in ovary, even though they were 
first described by Urist in 1965 as an inducer of osteogenic cells capable of producing bone. Non-
osteogenic processes include signalling of epidermal induction and developmental processes 
including cell differentiation, morphogenesis and apoptosis. They execute their actions by 
binding to 2 types of activin like receptor kinases (ALK), type I (A or B, ALK-3 or ALK-6 
respectively) and type II. Both types possess intrinsic serine/threonine kinase activity. BMP 
receptor IB is phosphorylated by BMP-R II, and these form a complex which phosphorylates 
mediator Smad proteins for the signal to be transducted (Chen, et al. 2004; Juengel and McNatty 
2005; Shimasaki, et al. 1999). Many of the TGF-β family members share chemical signalling 
pathways, and the mechanisms seem to be similar among each other, at least for the most studied 
of them. This mediation can be typified by the activin signalling mechanism, as the BMP 
receptors show. 
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Fig. 22 – BMP signalling and its regulation (Source: Granjeiro, et al. 2005). R-Smads or receptor regulated Smads 
are a class of proteins that act in response to signals by the TGF-β superfamily of ligands, associating with receptor 
kinases and being phosphorylated at an SSxS motif at their extreme C-terminus. These proteins then typically bind to 
the common mediator Smad or co-Smad or Smad4 (Chen et al. 2004; Findlay et al. 2002). Smad complexes 
accumulate in the cell nucleus where they regulate transcription of specific target genes (Welt et al. 2002). Smad6 or 
7 bind type I receptors and prevent Smad 1, 5 or 8 activation. (Chen et al. 2004; Granjeiro et al. 2005). 
 
 
In fig.16 of the results we see that in primary oocytes the signal gets stronger compared to 
oogonia, but it’s still considerably low when compared to its expression in vitellogenic phases. 
Both early and late vitellogenic show high expression of this receptor. Two BMPs, BMP-4 and 
BMP-7, and receptor IB were shown to be expressed in rat ovaries, with BMP-4 and -7 
expression higher in thecal cells and receptor expression higher in granulosa cells. Their 
physiological concentrations cause either stimulating or inhibitory effects on steroidogenesis 
induced by FSH (Drummond 2005; Findlay et al. 2002; Nilsson and Skinner 2003). So granulosa 
cells are probable targets for BMPs. A BMP system for regulating FSH activity and sensitivity in 
granulosa cells during follicle growth has been proposed for mammals: FSH stimulates estrogens 
and progesterone production by signalling expression of steroid enzymes (Shimasaki et al. 1999). 
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Smad proteins (fig. 22) and cyclic AMPs mediate BMPs and FSH signalling, respectively, thus 
differential regulation might occur with interaction of these 2 pathways. BMP might enhance 
estrogen production by increasing FSH signalling by the Smads cascade, which results in an 
increased activity of aromatase P450 (Findlay et al. 2002; Shimasaki et al. 1999). The results of 
the RT-PCR to BMP-R IB seen in figure 16 show an increased expression in both vitellogenic 
stage and mature oocytes, suggesting a possible similar system as to the mammalian FSH-BMP 
signalling with Smads. Receptor expression rises and so does aromatase (CYP19a) in these 2 
later stages. Furthermore it was also showed that BMP-R IB, FoxL2 and CYP19a expressions are 
positively correlated (table 3). Thus, it is possible that this effect of amplification of FSH by the 
Smad signalling cascade is being observed in the studied teleost. A mutation in BMPR-IB has 
been associated with abnormal ovulation rate (Nilsson and Skinner 2003) and its total absence 
leads to infertility (Findlay et al. 2002), indicating a possible role in its regulation, something 
supported by the higher expression found at late vitellogenic and mature oocytes. In the oocytes 
expression of BMP-6 and BMP-15 has been detected (Findlay et al. 2002; Nilsson and Skinner 
2003), indicating paracrine BMP-ligand interactions in the follicle and possibly an autocrine 
action of BMP-15 in regulating maturation (Juengel and McNatty 2005). These factors produced 
at the oocytes are substrates for BMP-R IB (Juengel and McNatty 2005) and may suppress 
granulosa cell expression of LH receptor and thus of MIH, indicating a role in granulosa cell 
differentiation and maybe in inhibition/delaying of luteinization (Findlay et al. 2002; Juengel and 
McNatty 2005; Knight and Glister 2003; Nilsson and Skinner 2003; Shimasaki et al. 1999). 
However, receptors in oocytes are interacting with BMPs synthesized in other tissues, like BMP-
4 and -7, which in the possibility of having the effects described above, could be also playing 
some role in oocyte maturation. These cells are under the influence of several hormones and 
growth factors, the most important of which are gonadotropins and IGF-I. It is definitely possible 
that BMPs act differently at each cells’ level (Khamsi and Roberge 2001). 
 
 
 
CPI-17 
 CPI-17 (cysteine protease inhibitor) is a 147 residue cytosolic protein (17 kDa) that 
inhibits type 1 protein serine/threonine phosphatases (PP1) (Matsuzawa, et al. 2005; Mueed, et al. 
2005; Woodsome, et al. 2001). It can be activated by phosphorylation by protein kinases, but the 
only evidence until now resides with protein kinase C, a Ca2+/phospholipid-dependent protein 
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kinase (Walsh et al. 2007). CPI-17 is phosphorylated by PKC at Thr38 which potentiates CPI-17 
activity as an inhibitor of phosphatases and elevating Ca2+ sensitivity in muscle (Takizawa, et al. 
2002; Walsh et al. 2007). PP1 control cellular functions like muscle contraction, cell division, 
transcription and metabolisms by desphosphorylation (Eto, et al. 1997). Major knowledge reflects 
CPI-17 action on myosin light chain phosphatase inhibition in mammals (Woodsome et al. 2001). 
Actin and myosin are present since the previtellogenic stages in connection with the oolema and 
may be involved in oocyte expulsion by contractile movements (Ryabova, et al. 1994); CPI-17 
(fig.17) decreasing expression in vitellogenic stages suggests it. PKC-induced maturation seems 
to involve some kind of action by the CPI-17 gene which would inhibit the myosin light chain. In 
Xenopus laevis myosin is also expressed during cortical granule exocytosis interacting with 
cysteine string proteins (Schietroma, et al. 2007). Furthermore, PP1, along with PP2 might be 
important in regulating stimulation of steroidogenic activity, by cAMPs which are the signalling 
molecules for FSH (Gonzalez Reyes, et al. 1997). So, CPI-17 lower expression seen in fig. 17 
might represent a decrease in PP1 inhibition by the CPI-17, which seems to cause an increase of 
FSH induced steroidogenesis. A higher level of expression in oogonia and primary oocytes 
indicates a possible great importance in some early oocyte development process, inhibiting some 
PP1 that otherwise would desphosphorylate some other component, activating or inactivating it 
and creating an abnormal effect. In conclusion, CPI-17 is probably involved in the regulation of 
cellular differentiation, and then at the later vitellogenic stages, its decrease will augment 
stimulation of steroidogenesis as well as allow contractile movements of myosin which will be 
necessary for ovulation. To know more of the CPI-17 gene sequence for the Mozambique tilapia, 
RACE-PCR was to be conducted and will be, in order to have the full sequence (see annex IX).   
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SART, PPMP, XP2 and Clone 26 
Figure 18 and 19 show expression patterns for other sequences. SART is an equivalent of 
dermatan sulfate epimerase standing for squamous cell carcinoma-associated reactive antigen for 
cytotoxic T cells (specifically SART-1). This gene has been strongly related to atopy, an allergic 
hypersensitivity caused by indirect contact with an allergen (Wheatley, et al. 2002). What could 
be its function in the ovary? Maybe there is some kind of link with abnormal ovary development. 
Constant expression suggests this gene to be essential throughout folliculogenesis. The protein 
with the PPMP motif seems to be essential in previtellogenic stages. Hypothetical protein XP2 
has also been detected in zebrafish ovary and expression pattern suggests some type of 
commitment in ovary recrudescence also with a possible primary role in cellular differentiation. 
Clone 26 too, but the sequence doesn’t have any homology with others; might be alternative 
transcript, a new gene or an UTR. 
 
 Table 3 and annex VIII show correlation coefficients for expression of each pair of genes 
tested. The most interesting correlation occurs for FoxL2, CYP19a and BMP-R IB, with 
possibilities for these patterns described above. Significant correlations can also be found 
between CPI-17 and Vasa, although no relation can be made between them at the moment. 
RBMX and Aly are positively correlated too. All the other genes that showed correlation can’t be 
related as for some their identity isn’t established.  
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5. CONCLUSIONS AND FINAL CONSIDERATIONS 
This thesis presented a view on the development of the ovary, its regulation, what there is 
left to know and what could benefit from the pursuit of knowledge in this area. The ovary 
can’t be only seen as the female gonad, it is as well a complex endocrine gland. The 
hypothalamus-pituitary-gonadal axis controls its development and maintenance, but the only 
factors or hormones well known to control these processes are described from the axis point of 
view. Factors involved in the recognising, signalling, and other decisive steps are still lagging, 
but they are there and should provide info on what and how the developing tissues change 
their morphological and biochemical characteristics or how the physiological processes work 
in their totality. It was mentioned the supposed relevance of TGF-β family in ovary 
development, with activin being the responsible for FSH incorporation in follicles. BMPs also 
showed to have a possible role, as they might enhance estrogen production by rising FSH 
signalling by the Smads cascade, which results in an increased activity of aromatase P450 
Receptor IB expression was equally more expressed in later stages and correlates with 
CYP19a expression and also FoxL2. RBMX and Aly can be the hnRNPGs that might involved 
in splicing and RNA export, respectively. Genes with decreasing expression probably have a 
major role in cellular differentiation, genes with increasing expression might have major role 
in maturation and genes which presented no statistically difference among groups are probably 
involved in basic cell functioning and are essential to proper development of the ovary. There 
is sense to this data, which should definitely bring ideas for more work to follow. Further 
studies on genes like FoxL2 or RBMX may actually provide solutions for genetic diseases. 
However, the problem with 18S as reference gene has not been fully resolved, although the 
results seem to suggest that the accumulation effect is not being observed. The best thing to be 
done would be to repeat the methodology and keep genomic DNA for proper quantification, or 
maybe just find some other reference gene like it was tried with Vasa, for instance elongation 
factor 1α. It would also be interesting to compare this data with hormone levels in the blood 
and apply some more techniques that would reveal more reliable information. As for each 
gene’s study, the full sequences need to be obtained, and then a functional analysis must be 
carried out, along with studies on the promoter, and in situ determination of expression to 
distinguish expression in follicle cells from expression in oocytes. 
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7.1. ANNEX I 
REAGENTS DESCRIPTION 
 
0,5x TBE (Tris - Borate - EDTA) Buffer – 5 Primer 
- 200 ml 5x TBE  
- 800 ml Sterile H2O 
  
1Kb+ ladder (1:20) - Invitrogen 
- Water (sigma) 380 µl 
- Ladder 20 µl 
- Loading buffer before use (10 µl) 
 
5x RT Buffer 
- 250 mM Tris-HCl pH 8,3 
- 375 mM KCl 
- 15 mM MgCl2 
- 50 mM DTT 
 
Bouin 
- 75 ml saturated aqueous solution of picric acid   
- 25 ml formaldehyde 
- 5 ml acetic acid 
 
DEPC-treated water  
- 200 µl of diethylpyrocarbonate (100 µl DEPC / L of water) 
- Water (sigma) to 2 L 
- Agitate and wait 24 hours 
- Autoclave at 121ºC for at least 40 minutes 
 
 
 
 
 
III
dNTPs 
Dilutions of each nucleotide 1:10 (10 mM each from 100 mM stocks) 
For 1 ml: 
- 100 µl dATP 
- 100 µl dTTP 
- 100 µl dCTP 
- 100 µl dGTP 
- 600 µl sigma water 
 
EtBr (500 mg/mL) 
- EtBr 1% 250 µl  
- Sterille distilled H2O 4750 µl 
 
LB 
- 1 pellet of LB agar (Sigma-Aldrich) / 50 ml de dH2O  
- Autoclave. 
 
Loading buffer  
- 40% glucose (40g in 100 ml) 
- Bromophenol blue (just a few grains) 
- Sterilize with seringe coupled to an adapter filter (0,2 µl) 
 
 SOC medium 
Formulation per one liter: 
- 10 mM magnesium chloride 
- 10 mM magnesium sulfate 
- 20 mM glucose 
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7.2. ANNEX II 
 
OPTIMIZATION PROCEDURES 
 
Testing primers 
 Primers were tested with a normal PCR reaction using the basic protocol, using tilapia 
ovary cDNA. If working correctly (amplifying only one band), they would then be tested with a 
certain oocyte cDNA so cDNA wasn’t wasted. If they amplified more than one band, it was 
necessary to previously play with MgCl2 quantities and annealing temperatures. The right amount 
of cycles was tested as described next, if it wasn’t possible to infer from previous results. 
 
 
Fig. 1 – Testing primers a) XP2, -) negative control, b) clone 9, c) clone 21, d) clone 21 .2 (different pair of primers); 
e) clone 26, f) vasa .1, g) vasa .2, h) vasa .3, i) PPMP22, j) SART .1 and k) SART .2. 
   
 Optimization procedures were required for some pairs of primers. The protocol used had 
1,5 µl of MgCl2 in the reaction, but when with this quantity it was obtained more than one band, 
it was necessary to determine the right amount of MgCl2 to be used for each set of primers. For 
this, it was done PCR using different amounts of it, varying from 0,5 µl to 1,25 µl (rest of volume 
compensated with SIGMA water). 
 
Fig. 2 – Expression of XP2 in ovary and testes shows different bands being produced for each. These bands were 
purified and sent to sequence. 
  a        -      Kb      b        c        d        e       f        g        h        i         j        k 
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For determining the best temperature for the annealing step, the PCRs were done on a 
iCycler from Biorad. This thermocycler allows for different temperatures to be applied in the 
different rows of the machine plate. The number of cycles to be used for a proper quantification 
was determined by having around 8 tubes or more, depending on previous knowledge on 
amplification, and then the tubes were taken out one by one, at a certain amount of cycles, and 
from there on after each 3 cycles (18x, 21x, 24x, 27x, 28x, 31x, 34x, 37x, 40x and more if 
necessary). 
 
  
            
 
Fig. 3 – Optimization of number of cycles to be used in RT-PCR for some of the genes. a) Clone 30, b) RBMX, c) 
CPI-17, d) clone 15, e) Aly, f) XP1, g) CYP19a, h) Twist-Neighbour. Number of cycles: 18, 23, 27, 30, 33, 36, 39, 
42 and 45x. i) 18S number of cycles optimization for some of the cDNAs to be used. By knowing the expression in 
these and comparing to previous tests and cDNA quantities it would be possible to infer about the most adequate 
number of cycles to be used for all cDNAs. 
 
 
 
 
 
a) b) c) d)
e) f ) g) h) 
i) 
  F6OO   F6PO 
  F14EV    F14LV/M 
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7.3. ANNEX III 
 
DNA ELECTROPHORESIS 
 
- Preparation of an agarose gel (1,5%, 2% or 3%) 
Four grams of agarose were dissolved in 200 ml of 0,5x TBE (Tris-Borate-EDTA) Buffer 
(for a 2% gel). With more agarose put into a fixed volume of Buffer, the pores will get smaller, 
something convenient for smaller fragments. This buffer is used to separate the DNA in both 
agarose and polyacrylamide gels, and it was prepared from a stock at 5x, being diluted in Elix 
water. The agarose was dissolved in the TBE by heating (microwave oven at mid-high 
temperature) and when it was completely dissolved, it remained at room temperature until 
cooling to around 50ºC. Then 200 µl of EtBr (500 ng/ml) were put into the still liquid gel. The 
liquid was then put into the electrophoresis mould previously prepared with tape on the ends and 
with combs, to solidify.  
 
- Electrophoresis 
Electrophoresis separates DNA fragments by size, applying an electric current with an 
energy source. The DNA is put near the negative electrode (anode), and as it is negatively 
charged because of the presence of phosphate groups, it will migrate in the direction of the 
positive electrode (cathode). A DNA ladder is always put into one of the wells for determination 
of band size. To the PCR products it was added loading buffer (composition) and the samples 
were put into the wells and run at 120 V and 200 mA. The gel was then transilluminated with UV 
radiation on a ImageMaster VDS from Pharmacia Biotech or a Biorad Gel Doc 2000 when 
quantification was required.    
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7.4. ANNEX IV 
 
RNA MIGRATION AND THE ABSENCE OF GENOMIC DNA CONTAMINATION 
 
 
Fig. 1 –RNA extracted from oocytes from the 8 females to oogonia, primary oocytes, early and late vitellogenic 
oocytes (1 µl). a) and b) F15 total ovary RNA. 
 
 
 
Fig. 2 – PCR (18S) to RNA samples treated with rDNAse I for purity confirmation. (*) Positive control. 
 
 
 
 
 
 
 
 
 
 
 
 
  F6                 F8               F10               F11                F12               F13              F14         a            F15            b    F10SS      F13SS      F12M 
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7.5. ANNEX V 
 
BAND PURIFICATION FROM AGAROSE GEL, CLONING AND SEQUENCING 
 
Cloning is the process of insertion of a DNA fragment to a DNA vector (plasmid) to be 
replicated to obtain various copies of the fragment. This plasmid with the pretended sequence is 
put into a host, usually bacteria, and its replication apparatus will replicate the DNA plasmid. The 
vector used was pGEM-T Easy (Promega), which is sold already open, not circular, and its 3’T 
extremities allow for the direct ligation of the PCR products, when these are synthesized with 
certain DNA polymerases, like Taq, that add a final adenine residue to the 3’end. This vector 
confers resistence to ampicillin, which will allow distinction between transformed and non 
transformed bacteria that will not grow in culture medium with ampicillin. Moreover it will allow 
the selection of the transformed bacteria by white-blue selection. This method consists in that the 
DNA is inserted in the middle of the gene coding for the enzyme β-galactosydase, thus if the 
DNA wasn’t inserted in the gene, it will continue to produce the protein that will keep on 
degrading the X-Gal inserted in the medium, producing the blue coloration. If the plasmid was 
inserted the gene won’t be transcripted and the bacteria will present a white coloration. These 
will be the selected bacteria for further replication and isolation of the plasmids containing the 
fragment desired. To verify the presence of the fragment on the host, a PCR to colonies can be 
made. The obtained replicated plasmid can then be isolated from the cells, by disrupting these 
with a mini-prep that will contain only the plasmid for various uses, including for sequencing.  
  
Band purification from an agarose gel 
 The bands were excised with the help of UVs and put in 1,5 ml eppendorfs and were 
purified using the GFX DNA purification kit from GE Healthcare. 300 µl of Capture Buffer (or 
10 µl for each 10 mg of gel) were put in the tube with the excised bands and put at 60ºC for 15 
minutes. A GFX column was put into a collection tube for each band to be purified. The 
dissolved agarose was put into the column, samples stayed at room temperature for 1 minute and 
then the tubes were centrifuged for 30 seconds. The collection tubes were emptied and 500 µl of 
Wash Buffer was added to the column. These were again centrifuged for 30 seconds. The column 
was discarded and the columns were put into a fresh and sterile 1,5 ml eppendorf tube. Finally it 
was added SIGMA water directly on top of the fibre matrix to suspend the DNA and left 1 
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minute at room temperature. Volumes depended on the quantity of DNA presumably found on 
the gel for each band, varying between 30 µl for weaker concentrations of DNA, to 50 µl for 
more intense bands. Samples were centrifuged one last time for 60 seconds and the retrieved 
purified DNA was kept on a new tube and stored at -20ºC.  
 
Ligation  
Ligation was done to the vector pGEM-T Easy (0,3 µl). The vector was kept at -20ºC and 
when removed from the fridge was briefly centrifuged to collect the vector at the bottom of the 
tube. Reaction would take place in a total of 10 µl, being 1 µl of 2x Rapid Ligation Buffer, 0,5 µl 
of T4 DNA Ligase, a designated volume of the PCR product and completed with SIGMA water. 
Reactions were mixed with repeated pipetting and left at 4ºC overnight for a maximum number 
of transformants.  
 
 
Transformation of competent bacteria 
  
The entrance of the plasmid DNA through the bacteria cell membrane requires special 
physiological conditions, a state known as competence, meaning the bacteria are able to 
incorporate exogenous DNA. This can be a natural occurring property of the bacteria, or can be 
induced with CaCl2 or sudden changes in temperature. These change the permeability of the 
membrane allowing the entrance of the plasmid. The quantity of DNA used is between 5 to 100 
ng, as too much DNA can inhibit the transformation. 
 
 Preparation of LB/ampicilin/IPTG/X-Gal plates 
LB was liquefied until boiling in the microwave oven and put in a 55ºC bath for 
approximately 1 hour. For 200 ml of LB were added 200 µl of ampicillin (80-100 µg/ml), 100 µl 
IPTG (0,5 mM) and 320 µl X-Gal (80 µg/ml) in a laminar flux chamber. 200 ml are enough to fill 
10 plates. These would stay in the chamber solidifying and then put at 4ºC until used. 
 
Transformation 
 The bacteria (XL1B) were removed from -80ºC and left unfreezing on ice. Ligation 
reactions were centrifuged briefly and 2 µl of it were added to 50 µl aliquot of the bacteria 
previously mixed by gently flicking the tube. The contents were gently mixed and put on ice for 
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20 minutes. Cells were then heat-shocked at exactly 42ºC so the vector would be incorporated by 
the bacteria, and put immediately on ice for 2 minutes or until the plates were ready. The bacteria 
were then prepared to be plated on the LB/ampicilin/IPTG/X-Gal plates. Plates were incubated 
overnight at 37ºC.  
 On the next day there would be both white and blue colonies. The blue colonies represent 
bacteria that don’t have the vector incorporated and thus continue to produce the antibiotic. The 
white colonies on the other hand contain the vectors and were selected and put at 37ºC on a SOC 
medium with shaking overnight for the bacteria to reproduce. Then mini-preps are made with the 
grown bacteria. 
  
 Mini-Prep 
 1,5 ml of the grown culture were put into an eppendorf tube. Then it was centrifuged 1 
minute at 13,400 rpm and the supernatant was discarded. To the pellet of bacteria were added 100 
µl of P1 solution with RNAse (10 µl / 1 ml of DEPC water). Tube was shaken in the vortex and 
solution P2 was added for lysis of bacteria. It was then incubated 5 minutes at room temperature. 
Finally P3 was put into the mix for precipitation of the larger bacteria DNA. It was shaken by 
inversion and left for 10 minutes on ice. After the tube is centrifuged 5 minutes at 13,400 rpm 
and the supernatant with the plasmid is retrieved. Then 2 x volume in tube of ethanol 100% and 
these were mixed by inversion and centrifuged 2 minutes at 13,400 rpm. Repeat wash with 70% 
ethanol 2x volume. Centrifuge 1 minute, discard ethanol and suspend plasmid in 40 µl of Sigma 
water.  
  
Colony PCR 
One of the white colonies was transferred to 75 µl of LB ampicillin and incubated at 37ºC 
during 3 hours. Then 1 µl of this culture was used as the template for the PCR with an initial 
denaturation during 10 minutes at 94ºC. 
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7.6. ANNEX VI 
 
PRELIMINARY EXPERIMENT 
Prior to the actual experiment, a test was made in order to detect differential expression of 
some genes in 3 different stages of oocyte growth. These were collected from one female (F0) at 
the middle of the cycle. Oocyte size was based morphological differences, being collected 
smaller oocytes (< 0,5 mm), medium sized oocytes (0,5-1,5 mm) and larger oocytes with more 
than 2 mm. These were compared with total ovary cDNA expression. Genes tested were 18S to 
use as reference, TN (Twist Neighbour), XP1 (hypothetical protein), BMP-R IB, Clones 15 and 
30, CPI-17, FoxL2 and the unidentified protein from the Aly/Ref family. The PCR reactions were 
previously optimized for MgCl2 quantities, annealing temperatures and number of cycles to be 
used.  
 
Fig. 1 – a) RT-PCR to female 0 cDNAs for total ovary RNA and small (S), medium (M) and large (L) oocytes and  
b) quantification of expression with 18S rRNA as reference. 
 
 The rest of the experiment was based on these results, even though some of these genes 
don’t appear on the final results, being replaced with others. They should be tested anyway, as 
they show differential sexual expression and also along oogenesis. All decreasing patterns created 
doubts on the use of 18S rRNA as the reference gene for quantification.   
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7.7. ANNEX VII 
 
PCR PRODUCTS OF RT-PCR TO ALL TISSUES 
 
Fig. 1 – Results for all genes of RT-PCR for all 8 females and stages of follicle development. 
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7.8. ANNEX VIII 
PEARSON PRODUCT MOMENT CORRELATION  
 
This statistical test shows indicates if there is a similar behaviour in the pattern of 
expression between each pair of genes. 
 
Table 1 – Pearson Product Moment Correlation for n = 30, with significant correlations between each pair of genes 
revealed in squared values. Significance was considered for P < 0,05, with positive correlation coefficient (CC) 
between pairs indicating they tend to increase together and negative CC values revealing an inverse behaviour by 
each gene. 
    BMP-R IB 
FoxL
2 CPI-17 RBMX Vasa XP2 Aly SART PPMP Clone 26
                        
            
CYP19a CC 0,565 0,697 -0,492 -0,581 -0,721 -0,605 -0,243 -0,269 -0,785 -0,581 
 P 0,00113 1,9E-05 0,00571 0,000751 7E-06 0,0004 0,195 0,158 2,9E-07 0,000764 
            
BMP-R 
IB CC  0,483 -0,319 -0,121 -0,254 -0,343 -0,258 0,0939 -0,393 -0,148 
 P  0,0069 0,0861 0,525 0,176 0,0636 0,169 0,628 0,0319 0,436 
            
FoxL2 CC   -0,332 -0,241 -0,363 -0,315 -0,0051 -0,0167 -0,444 -0,193 
 P   0,0727 0,2 0,0489 0,0897 0,979 0,932 0,0141 0,306 
            
CPI-17 CC    0,287 0,474 0,438 0,179 -0,0036 0,533 0,458 
 P    0,124 0,00819 0,0156 0,344 0,985 0,0024 0,011 
            
RBMX CC     0,885 0,829 0,52 0,76 0,81 0,797 
 P     8,21E-11 2E-08 0,0032 1,7E-06 6E-08 1,32E-07 
            
Vasa CC      0,868 0,538 0,647 0,922 0,926 
 P      5E-10 0,0022 0,00015 5,03E-13 2,50E-13 
            
XP2 CC       0,503 0,551 0,846 0,831 
 P       0,0047 0,00194 3,9E-09 1,35E-08 
            
Aly CC        0,408 0,417 0,443 
 P        0,0282 0,0218 0,0141 
            
SART CC         0,479 0,495 
 P         0,00863 0,00639 
            
PPMP CC          0,862 
 P          9,27E-10 
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7.9. ANNEX IX 
RACE-PCR (RAPID AMPLIFICATION OF CDNA ENDS PCR) 
RACE-PCR is a technique used to obtain the full sequence of a gene from a fragment. It 
consists in adding a poly-A in a differently synthesized cDNA that can then be amplified beyond 
the known sequence. The idea is to use the poly-A tail to anneal with a poly-T that will be added 
to the PCR reagents mixture and another primer from a site in the sequence, resulting in a longer 
sequence with possibly the full length gene, or at least a longer version of the fragment directed 
to the 5’ or the 3’ end. This synthesis however can be The RACE was done to retrieve the full 
sequence of the CPI-17 gene, occurring in a total of 25 µl per tube with positive and negative 
controls. 
 
cDNA synthesis: 
 
Protocol 1 
Each compoment was mixed and centrifuged briefly before use. To a volume with 3 µg of 
tilapia ovary RNA 1 µl of primer ND-CPI-rv1 (10uM) was added and H2O up to 6 µl. This was 
incubated at 65ºC during 5 minutes and centrifuged briefly and put on ice during at least 1 
minute. The next mix was added: 
           - 1 µL 10X first strand buffer 
           - 1 µl 0,1 M DTT 
           - 0,5 µl dNTP (10mM each) 
 Incubation at 42ºC during 2 minutes, 1 µL of Supercript II RT (Invitrogen) added and 
incubated at 42ºC during 2 minutes. 1 µl of BD Smart CDS primer IIA (5µM) was put into the 
tube and reaction was run at 42ºC during 15 minutes. Add MnCl2 (20 mM) and incubate at 42ºC 
during 15 minutes. End reaction at 70ºC during 15 minutes. 
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Protocol 2 
To a volume with 3 µg of the RNA to be used were added 0,5 µl of specific primer (20 
µM) ND-CPI-rv1 and then up to 13 µl with H2O DEPC or sigma. Mix was incubate 10 minutes at 
70ºC and centrifuged briefly and placed on ice during at least 1 minute. Then the next mix was 
added:  
-2 µl of 10x rt buffer 
-1 µl of dNTPs (10 mM each) 
-0,5 µl DTT 
-0,5 µl RNA guard 
-2 µl of H2O 
The mixture was incubated 2 minutes at 42 ºC, 0,5 µl of Superscript II RT (Invitrogen) were put 
together and the reaction was run for 75 minutes at 42ºC. 
 
Tailing: 
To 8 µl of the previous reaction (cDNA synthesis) were added: 
- 2 µl of rTdT buffer  
- 2 µl of ATP (2mM) 
- 7 µl H2O 
 
This mixture was incubated for 5 minutes at 70ºC, centrifuged briefly and placed on ice 
during at least 1 minute. Then again incubated 10 minutes at 37ºC, 1 µl of rTdT (enzyme) was 
put and incubated 10 min at 37ºC. The reaction was terminated at 65ºC for 10 minutes. 
 
 Fig. 1 – CPI-17 sequence for some vertebrate species and consensus regions. 
 
XVI
RACE-PCR was run for 35 cycles, with initial denaturation at 94ºC for 5 minutes and 
cycles of 94ºC for 30 seconds of denaturation, 57ºC during 30 seconds for annealing and 
elongation at 72ºC for 40 seconds. Primers used for 1st protocol synthesis were rv1 on table 2 in 
the methods section with BD smart and CPI rv1 with CPI rv2 at 25 µg/µl. For 2nd synthesis 
primers were CPI rv1 with oligo dT adapter and CPI rv1 with oligo dT (1 µg/µl) also at 25 µg/µl. 
 
 
Fig. 2 – Bands obtained with RACE-PCR for a 3rd synthesis not described. The desired sequences were not 
amplified. 
